WO1998011826A1 - Ultrasonic energy delivery system and method - Google Patents

Ultrasonic energy delivery system and method Download PDF

Info

Publication number
WO1998011826A1
WO1998011826A1 PCT/US1997/015870 US9715870W WO9811826A1 WO 1998011826 A1 WO1998011826 A1 WO 1998011826A1 US 9715870 W US9715870 W US 9715870W WO 9811826 A1 WO9811826 A1 WO 9811826A1
Authority
WO
WIPO (PCT)
Prior art keywords
transducer
power
frequency
temperature
automatically
Prior art date
Application number
PCT/US1997/015870
Other languages
French (fr)
Inventor
Marshall L. Sherman
Thomas M. Castellano
Original Assignee
Heart Rhythm Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heart Rhythm Technologies, Inc. filed Critical Heart Rhythm Technologies, Inc.
Priority to JP10514716A priority Critical patent/JP2000500059A/en
Priority to EP97941463A priority patent/EP0873082A4/en
Priority to AU43365/97A priority patent/AU4336597A/en
Publication of WO1998011826A1 publication Critical patent/WO1998011826A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • A61B17/2202Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00084Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00084Temperature
    • A61B2017/00092Temperature using thermocouples
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac

Definitions

  • the invention relates generally to power control, and more particularly, to a system and method for the more efficient transfer of energy from an ultrasonic power delivery system to biological tissue.
  • Improper growth of or damage to the conductive tissue in the hea ⁇ can interfere with the passage of regular electrical signals from the S-A and A-V nodes. Electrical signal irregularities resulting from such interference can disturb the normal rhythm of the hea ⁇ and cause an abnormal rhythmic condition referred to as cardiac arrhythmia. Arrhythmia can be controlled in many cases by ablating the errant hea ⁇ tissue.
  • the physician may use an ablation procedure to destroy the tissue causing the arrhythmia in an attempt to remove the electrical signal irregularities and restore normal hea ⁇ beat or at least an improved hea ⁇ beat.
  • Successful ablation of the conductive tissue at the arrhythmia initiation site usually terminates the arrhythmia or at least moderates the hea ⁇ rhythm to acceptable levels.
  • Electrophysiological (“EP”) ablation is a procedure more often employed in terminating cardiac arrhythmia. This procedure typically involves applying sufficient energy to the interfering conductive tissue to ablate that tissue, thereby removing the irregular signal pathway.
  • the distal end of an EP catheter may include mapping electrodes for locating the arrhythmia initiation site as well as an ablation device for performing the ablation procedure on the interfering conductive tissue.
  • mapping electrodes for locating the arrhythmia initiation site
  • ablation device for performing the ablation procedure on the interfering conductive tissue.
  • different catheters may be used for mapping and for ablation.
  • One type of device locatable at the distal end of a catheter for delivering ablation energy to biological tissue is an ultrasonic device, such as a piezoelectric transducer or crystal.
  • the piezoelectric transducer excited by electrical energy to oscillate at ultrasonic frequencies, impa ⁇ s acoustic energy to the target tissue thereby causing ablation.
  • an ultrasonic device is effectively an electrical to ultrasonic transducer and must be driven properly by electrical energy for effective power transfer.
  • Ultrasonic devices incorporating piezoelectric elements are in effect complex circuits that are a combination of resistance, capacitance, and inductance. In such systems, there are one or more frequencies where the total impedance of the circuit will appear purely resistive. These frequencies are referred to as resonant frequencies.
  • resonant frequencies For an electro-mechanical transducer such as a piezoelectric transducer comprising complex circuitry, it has been found that resonant frequencies occur in pairs of relatively closely-spaced frequencies where the impedance is resistive and the phase angle is zero. The first of these frequencies is the so-called series resonant impedance frequency, and the second is the so-called parallel resonant impedance frequency. Typically, the most efficient energy transfer occurs at a resonant frequency.
  • Resonant frequencies can vary substantially between different transducers depending on their physical structure. Additionally, the resonant frequencies of a pa ⁇ icular transducer can vary substantially depending on the loading on the transducer at the time. The environmental loading, such as the temperature to which the transducer is exposed, can cause a shift in the resonant frequencies as can changes in the tissue or contact loading on the transducer.
  • both the environmental and contact loading on an ablation transducer can vary widely.
  • the loading is increased.
  • the loading varies as the tissue is ablated or otherwise modified during the procedure and the temperature rises.
  • These variations in loao ⁇ ng can cause corresponding variations in the transducer's resonant frequencies, thereby causing variations in the efficiency of power transfer. Therefore, it is preferable to have a lower "Q" transducer so that changes in the loading of the transducer during an EP procedure do not cause an unacceptable lowering of the power factor.
  • a common method of determining resonant frequency is to apply an alternating current to the transducer and compare the resulting phase angle between the voltage applied to the transducer and the current drawn by the transducer.
  • the phase angle equals ninety degrees for purely inductive circuits and minus ninety degrees for purely capacitive circuits.
  • the phase angle equals zero for purely resistive circuits, with the voltage and current being in phase with each other.
  • a phase angle of zero also indicates a resonant frequency of the transducer.
  • this method of determining the resonance frequency is undesirable because the instruments required to determine the phase angle between voltage and current are relatively expensive and are less effective at higher frequencies, such as at 10 mHz.
  • those handling a catheter with an ablation crystal mounted on its distal end may drop the distal end of the catheter subjecting the crystal to a sharp shock. If the crystal is too thin, it may crack thereby rendering it unusable. If the crystal is too thick, it will be difficult to introduce it into a patient.
  • the ablation device should have a reasonable coefficient of thermal conductivity so that heat reaching the device during an ablation procedure will be conducted rapidly by the device. Controlling the temperature at the ablation device is impo ⁇ ant so that blood boiling and tissue coagulation on the device do not occur. Coagulated tissue on the ablation device can cause an over-loading condition and the crystal may actually cease its vibrations if such loading exceeds the device's limit. It would be desirable to put a temperature sensor in the ablation device to monitor the temperature of the device and control the energy provided to the device to hold the temperature within limits.
  • the ablation device does not conduct thermal energy at a rapid rate or uniformly, the device may be hotter in one area than in another. If the temperature sensor is placed in a lower temperature area, higher temperatures causing blood boiling and coagulation at another pa ⁇ of the device may not be detected early enough. Thus, providing a crystal with relatively rapid thermal conductivity, sensing the temperature at the crystal, and controlUng the energy supplied to the crystal for ablation are desirable.
  • those skilled in the a ⁇ have recognized a need for an energy delivery system and method that can provide improved energy delivery to biological tissue.
  • those skilled in the a ⁇ have recognized a need for an energy delivery system and method that can determine the optimal operation frequency of a transducer in-vivo relatively inexpensively and simply.
  • the present invention provides a system and a method for applying acoustic energy to biological tissue, comprising a catheter having distal and proximal ends, an ultrasonic transducer that transduces electrical energy into acoustic energy, said transducer having first and second resonance frequencies, said transducer mounted at the distal end of the catheter, a temperature sensor mounted at the distal end of the catheter that senses temperature and provides a temperature sensing signal, a tuning system connected to the ultrasonic transducer providing electrical energy to the transducer and monitoring the transducer's response thereto to determine the first and second resonance frequencies of the transducer, said tuning system providing first and second resonance signals as a result of the determination, and a power supply that provides electrical energy to the ultrasonic transducer at a frequency that is halfway between the first and second resonance frequencies at a drive level dependent on the temperature sensed by the temperature sensor.
  • the invention provides processing means for calculating a center frequency as an average of the first and second resonant frequencies.
  • a biologically-compatible, non-metallic layer mounted on the outside of the ultrasonic transducer that lowers the frequency sensitivity of the transducer.
  • the processor decreases the power drive level when the temperature signal represents a temperature above a predetermined first threshold temperature.
  • the ultrasonic transducer is cylindrically shaped and the temperature sensor is mounted in the ultrasonic transducer.
  • the power supply comprises a power appHcation switch wherein the power supply automatically applies test power to the ultrasonic transducer to determine the first and second resonant frequencies and then applies full power as selected at the halfway frequency. Fu ⁇ hermore, the power supply automatically sweeps through a predetermined range of frequencies to determine the first and second resonant frequencies.
  • the power supply system holds the frequency constant while varying the power level to maintain the temperature within a predetermined range.
  • FIG. 1 is a diagrammatic view of a human hea ⁇ in pa ⁇ ial cross section showing an electrophysiological catheter disposed internally and located so that one side of a "side-fire" energy transducer mounted at the catheter's distal end is against the endocardium for performing an electrophysiological procedure;
  • FIG. 2 is an enlarged, pa ⁇ ially broken, cross-sectional side view of the distal end of the EP ablation catheter shown in FIG. 1 including a piezo-electric side-fire transducer having a plurality of temperature sensing devices;
  • FIG. 3 is an enlarged sectional side view of one of the temperature sensing devices in FIG. 2 showing its mounting configuration in the catheter;
  • FIG. 4 is an exploded perspective view of the distal end of the EP catheter shown in FIG. 2;
  • FIG. 5 is an enlarged cross-sectional view of the distal end of another embodiment of an EP catheter in which an "end-fire" ultrasonic transducer is formed with a convex- shaped tip and also includes a temperature sensing device disposed in the transducer;
  • FIG. 6 is a side view of the catheter of FIG. 2 showing its distal end disposed parallel to and in contact with an ablation site for "side-fire" use;
  • FIG. 7 is a side view of the catheter of FIG. 5 showing its distal end disposed perpendicularly to and in contact with an ablation site for "end-fire" use;
  • FIG. 8 is a diagram showing frequency versus power transfer for three ultrasonic transducers having different frequency sensitivities
  • FIG. 9 is a diagram showing shifted frequency versus power transfer curves for the three ultrasonic transducers of FIG. 8 that have undergone a temperature change
  • FIG. 10 is a schematic diagram illustrating an ultrasonic energy delivery system for controlling the drive level of an ablation device in accordance with the principles of the present invention.
  • FIG. 11 is a flow cha ⁇ illustrating a method for controlling the drive level in accordance with the present invention.
  • DET.AILED DESCRIPTION OF THE PREFERRED EMBODIMENTS in the following description, like reference numerals will be used to refer to like or corresponding elements in the different figures of the drawings.
  • EP electrophysiology
  • the catheter includes, in this case, an elongated catheter tube or body 18 having a distal end 20 with an electrode 22 mounted at the distal tip, a cylindrical ultrasonic transducer 24, in this case a piezoelectric device, mounted proximal to the tip electrode, and a band electrode 26 mounted proximal to the piezoelectric transducer 24.
  • the electrodes 22 and 26 and the piezoelectric transducer 24 may be individually or simultaneously actuated to perform various electrophysiological procedures.
  • FIG. 1 the distal end of the catheter is shown parallel to and in contact with the endocardium for performing a "side-fire" EP ablation procedure with the piezoelectric transducer 24.
  • a “side-fire” device is one that is mounted such that it conducts energy sideways in relation to the catheter shaft. This would include the transmission of energy in the radial direction.
  • An “end-fire” device is one that is mounted such that is conducts energy at the distal end of the catheter in relation to the catheter shaft. This would include the transmission of energy in the axial direction.
  • the distal end 20 of the elongated catheter body 18 is steerable and has sufficient torsional and axial rigidity for maneuvering the distal end through the vascular system and to selected sites within the hea ⁇ chamber.
  • the catheter body 18' is of sufficient length, for instance to allow for a transluminal percutaneous brachial approach to the hea ⁇ of an adult patient and/or a transluminal percutaneous femoral approach.
  • the distal tip electrode 22 may be a mapping type electrode used to send or receive electrical signals from adjacent endocardial tissue for locating aberrant conductive tissues.
  • Suitable materials for the tip electrode 22 include pure platinum, a platinum iridium alloy such as "platinum 10 iridium" (90% platinum 10% iridium), a gold alloy, pure titanium, and/or pure tungsten.
  • the band electrode 26, located proximal to the piezoelectric transducer 24, may also be used either individually or simultaneously with the tip electrode 22 to perform EP mapping procedures.
  • the cylindrical piezoelectric transducer 24 directs ultrasonic acoustic energy in a radial outward direction for "side-fire" operation. When transmitting ultrasonic energy radially outward, tissue located adjacent the transducer will be ablated.
  • the piezo-electric transducer or crystal 24 may be subject to overheating if precautions are not taken to control heat buildup. Heat buildup can be prevented by maximizing heat transfer away from the crystal 24.
  • silver is desired as the outer coating on the crystal. Silver is one of the most thermally conductive materials available, so heat created by ablating the patient is rapidly conducted into the blood flow. However, silver is not as bio-compatible as other materials.
  • the transducer has an exterior coating comprising a biologically-compatible, non-metallic layer 27 mounted on the outside of the ultrasonic transducer.
  • the non-metallic layer 27 serves to protect and strengthen the crystal as well as lowering the frequency sensitivity of the ultrasonic transducer.
  • the thickness of the bio-layer in one embodiment was selected so that the section of catheter having the bio-layer had the same outer diameter as the section of the catheter proximal to the bio-layer.
  • a pair of temperature sensing devices 28 are mounted in the wall of the cylindrical piezoelectric transducer 24.
  • two sensing devices are shown; however, more or fewer sensing devices may be mounted in the transducer.
  • three temperature sensing devices are mounted in the transducer wall and are spaced equi-angularly apa ⁇ (120 degrees) in a common transverse plane. As is discussed below, having a greater number of temperature sensing devices in the transducer may be more desirable to obtain an accurate temperature indication in a side-fire application.
  • the cylindrical transducer 24 has inner 30 and outer surfaces 32 and sensor bore holes 34 are formed completely through those surfaces and the wall 33 of the transducer.
  • Each of the sensing devices 28 is in the form of a point sensor mounted within the respective sensor bore hole.
  • the bore holes 34 may be formed through the wall of the cylindrical piezoelectric transducer by a non-mechanical contact, ultrasonic machining process available commercially.
  • the bore holes in one embodiment were 0.1778 mm (0.007 in.) in diameter. It is desirable that the temperature sensing devices 28 be as small as possible so that when the devices are mounted in the sensor bore holes of the piezoelectric transducer 24, the transducer's ultrasonic performance is minimally affected and the temperature response times are minimized.
  • thermocouples 33 used as the temperature sensing device 28 are shown.
  • the thermocouple includes an elongated electrical sensing lead pair 35 comprising individually insulated flexible electrical temperature sensing leads 36 and 38.
  • the electrical leads include respective electrically conductive wires, 40 and 42, formed of dissimilar materials.
  • the distal po ⁇ ion of each wire is stripped of its insulation 44 and is coupled with the stripped distal po ⁇ ion of the other lead to form the thermocouple.
  • one wire 40 is formed of copper and the other wire 42 is formed of constantan ("T" type).
  • the thermocouple 33 may be constructed of other dissimilar metallic materials.
  • the distal po ⁇ ions of the dissimilar wires 40 and 42 may be joined such as by welding or bonding together, for instance by condu ⁇ ive solder 46, to form the thermocouple junction along the length of the solder joint.
  • the electrical temperature sensing leads 36 and 38 are formed from a forty-four gauge (AWG) bifilar wire.
  • a bifilar wire of this so ⁇ is available from Hudson International of Trenton, Georgia and when conne ⁇ ed as shown, it forms a T-type thermocouple 33.
  • the dissimilar metallic wires may be joined by TIG or laser welding to form an enlarged weld bead defining the thermocouple jun ⁇ ion.
  • thermocouple junction In both configurations, electrical current may thus pass through the thermocouple junction to create the thermocouple effe ⁇ .
  • the opposite ends of the respective sensing leads 36 and 38 may be conne ⁇ ed to a conne ⁇ or (not shown) mounted on a manipulation handle at the proximal end of the catheter.
  • the sensing leads carry the sensing signals responsive to the temperature sensed at the thermocouple. Those sensing signals may be used by monitoring equipment to derive temperature indications.
  • the sensor bore hole 34 is of a -uniform diameter along its length.
  • a flejcible elastomeric tubular sheath 48 is provided for receipt within the sensor bore hole, the sheath having an inner bore 50 therethrough.
  • the tubular sheath is composed of an elastomeric polyamide having an inner bore 50 diameter sized for snug receipt of the pair of electric sensor leads 36 and 38 and having an outer diameter sized for a snug fit within the sensor bore hole 34.
  • the sheath 48 is pulled into the sensor bore hole 34 from the outside surface 32 of the transducer.
  • the length of the sheath is greater than the thickness of the wall of the transducer and the non-metallic layer 27 so that an excess length protrudes inwardly from the inner surface 30 of the transducer.
  • the outer surface of the sheath is cut or otherwise positioned such that it is flush with the outer surface of the non-metallic layer 27.
  • An annular bead 52 of an adhesive, such as cyanoacrylate, is applied around the periphery of the sheath along the inner surface of the transducer to secure the sheath thereto.
  • thermocouple 33 is positioned substantially at the same level or flush with the outer surface of the non-metallic layer 27 as shown in FIG. 3. Because the sheath extends inwardly past the edge of the bore 34, it provides a strain relief for the sensing thermocouple leads 36 and 38 as well as protecting them from the possible loss of their insulation layers 44 should they scrape against the transducer 24. Movement of the transducer 24 occurs due to the nature of a piezoele ⁇ ric transducer and such movement can be detrimental to sensor leads.
  • thermocouple, sheath, and non- metallic coating 27 are applied to seal and anchor the assembly as one as shown in FIG. 3.
  • a crown allows the thermocouple to be mounted flush with the outer surface of the non-metallic coating 27.
  • the non-metallic coating 27 provides a better acoustical impedance match between the piezoelectric crystal and hea ⁇ tissue for more efficient energy transfer as discussed below in more detail.
  • the coating 27 also provides a bio-layer and adds mechanical strength to the transducer.
  • piezoele ⁇ ric transducers will effect a pumping action of fluid through an associated orifice or opening due to the movement of the transducer. Fluid entry into the interior of an EP catheter is undesirable because it may significantly dampen the piezoelectric transducer's performance rendering the catheter effectively useless.
  • the approach described above and illustrated in the accompanying figures prevents fluid entry.
  • the use of a resilient sheath 48 compressed in the bore through the piezoelectric transducer 24 provides a first, main defense against leakage. By applying adhesive/sealant about the sheath on the outside and the inside provides fu ⁇ her protection against leakage as well as performing other functions described above.
  • the construction of the distal end 20 of the catheter will be described including the assembly of the distal end electrode 22, the cylindrical piezoelectric transducer 24, and the band electrode 26 onto the distal end of the catheter.
  • the distal tip electrode 22, piezoelectric transducer 24, and band electrode 26 are mounted to a mounting member or base 58 and the base is mounted to the distal end of the catheter body 18.
  • the mounting base 58 is generally an elongated cylindrical body having a longitudinal axial bore 60 therethrough.
  • the distal end of the base has a head 62 formed with an annular O-ring retention groove 64.
  • the base is formed with a smaller diameter neck 66 extending in the proximal dire ⁇ ion from the head 62 to a larger diameter flange 68 also formed with an annular O-ring retention groove 70.
  • a radial sensor lead bore 72 is formed through the wall of the neck 66, generally at the medial po ⁇ ion thereof.
  • Formed proximally from the flange 68 is a larger diameter shoulder 74 having a flat surface 76 along one side.
  • the flat surface 76 provides room for a welding joint of an electrical lead to the ele ⁇ rode, as discussed below.
  • An ele ⁇ rode lead bore 78 is formed from the flat surface radially inwardly to the axial bore 60.
  • the shoulder 74 from the proximal end thereof, u ⁇ her expands radially to a larger diameter abutment plate 80 and is formed therefrom with a smaller diameter elongated mounting stem 82 (shown pa ⁇ ially broken in FIG. 2).
  • the base 58 is electrically insulative and may be formed of VLTEM for example.
  • the tip electrode 22, in the embodiment shown in FIGS. 2 and 4, is generally bullet-nose in shape but may take other shapes.
  • the proximal end of the tip electrode 22 is formed with a small diameter, axially proje ⁇ ing mounting post 84 in this embodiment.
  • the proximal end of the post is formed with an axial electrode connector bore 86 for connection to an elongated electrical conductor wire 88 having an insulative jacket 90.
  • the insulative jacket at the distal end of conductor wire 88 is stripped away and the distal tip of the wire conductor 88 is received within the connector bore 86.
  • the conductor is affixed to the tip electrode by crimping the post 84 about the conductor or by soldering the conductor thereto, or by other means.
  • the length of the conductor wire 88 is selected such that the conductor may extend and attach to an electrical connector at a manipulation handle (not shown) at the proximal end of the catheter 10.
  • the conductor wire is formed of a high strength copper beryllium that conducts electrical signals from the tip electrode to the connector at the proximal end of the catheter.
  • the conductor wire acts as a safety chain to ensure that the tip assembly remains on the catheter shaft while being used in an EP procedure.
  • the piezoelectric transducer 24 has an outer diameter that is just slightly less than the catheter body 18 and the tip electrode 22 so that the diameter is the same when the non-metallic coating 27 is applied.
  • the transducer 24 may be composed of a ceramic crystalline material.
  • the outer 32 and inner 30 surfaces of the transducer have a thin film, electrically condu ⁇ ive metaflic coating (not shown) such as gold, silver, or nickel disposed thereon to provide transducer excitation electrodes.
  • a first electrically conductive transducer wire 92 is soldered to the metallic coating disposed on the outer surface 32 of the transducer at the proximal end thereof.
  • a second ele ⁇ rically conductive transducer wire 94 is soldered to the metallic coating disposed on the inner surface 30 of the transducer at the distal end thereof.
  • Each of the transducer wires has an ele ⁇ rically insulative jacket (not shown) that insulates the respe ⁇ ive wires along their lengths to prevent sho ⁇ circuiting.
  • the band ele ⁇ rode 26 is generally a thin walled ring having an outer diameter substantially the same diameter as the catheter body 18, and the tip ele ⁇ rode 22. The inner diameter of the band is sized for mounting over the shoulder 74 of the base 58.
  • the electrode band is electrically conductive and may be formed of platinum or gold or other materials.
  • An electrical sensor lead 96 is provided and has its distal end bonded to the inner surface of the band, for instance by soldering or weldment.
  • the electrode sensor lead 96 has an electrically insulative jacket (not shown) that insulates the lead along its length.
  • the catheter body 18 is formed with a longitudinal inner lumen 97 that extends the entire length of the body to its proximal end.
  • the distal extremity of the catheter body is formed with an annular mounting hole 99 having an inner diameter sized for receipt of the mounting stem 84 of the base 58.
  • the proximal end of the electrode sensor lead 96 of the electrode band 26 is passed inwardly through the electrode lead bore 78 of the base 58 and extended in a proximal direction out through the inner bore 60 thereof.
  • the electrode band is thereafter assembled over the shoulder 74 of the base into contact with the abutment plate 80.
  • the band is adhesively bonded to the shoulder, for instance using epoxy, to securely affix the band electrode to the base.
  • a pair of elastomeric O-rings 98 and 100 are provided to center the piezoelectric transducer 24 on the mounting base 58 at the catheter distal end and fix it in position. They also vibrationally isolate the piezoele ⁇ ric transducer 24 from the other components of the catheter 10.
  • the first O-ring 98 is positioned in the second retainer groove 70 of the flange 68 at the proximal end of the neck 66.
  • the second O-ring 100 is disposed within the first retainer groove 64 at the head 62 of the base.
  • the O-rings 98 and 100 may be composed of a low durometer material such as a silicone based polymer that provides sufficient high frequency vibration isolation characteristics while providing sufficient hardness such that the ultrasonic vibrations generated from the piezoele ⁇ ric transducer 24 are not unduly damped.
  • a low durometer material such as a silicone based polymer that provides sufficient high frequency vibration isolation characteristics while providing sufficient hardness such that the ultrasonic vibrations generated from the piezoele ⁇ ric transducer 24 are not unduly damped.
  • the piezoelectric transducer 24, having the temperature sensing devices 28 mounted thereto, is then mounted to the base 58.
  • the first transducer wire 92 at the distal end of the transducer is received inwardly through the ele ⁇ rode lead bore 78 beneath the ele ⁇ rode band 26 and dire ⁇ ed in a proj imal direction through the inner bore 60 of the base.
  • the second transducer wire 94 at the distal inner end of the transducer, along with the respe ⁇ ive temperature sensor lead pairs 35 of the respective temperature sensing devices 28 are guided inwardly into the sensor lead bores 71 and 72 of the neck 66 of the base 58.
  • the cylindrical transducer 24 is then mounted over the O-rings 98 and 100 and the neck of the base.
  • the proximal end of the transducer is spaced a sho ⁇ distance from the electrode band 26 and an electrically insulative spacer bead 102 (FIG. 2) of adhesive/sealant is appHed between the band 26, base 58, and transducer 24 to seal the space between the transducer 24 and the electrode band 26 and affix the transducer 24 in position.
  • the adhesive/sealant is of a low durometer, bio- compatible adhesive/sealant and may be composed of a silicone-based polymer having sufficient vibrational isolating and electrical insulating characteristics.
  • the proximal end of the tip conductor 88 of the tip electrode 22 is then received within the distal end of the inner axial bore 60 of the base 58 and the mounting post 84 of the tip electrode pressed into the distal end of the inner bore 60.
  • adhesive such as epoxy, bonds the mounting post within the inner bore 60 of the base.
  • the proximal surface of the tip electrode is spaced a sho ⁇ distance from the distal end of the piezoelectric transducer 24 and a second electrically insulative spacer bead 104 of adhesive/sealant is applied between the tip electrode 22, base 58, and transducer 24 to seal the space between the transducer and the tip electrode affixing the transducer in position.
  • This adhesive/sealant is also a low durometer, bio-compatible material having sufficient vibrational isolating and ele ⁇ rical insulating characteristics.
  • the combination of the two internal O-rings 98 and 100 and the two adhesive spacing and sealing beads 102 and 104 at either end of the piezoelectric transducer optimize the transfer of acoustic energy from the transducer to the tissue.
  • the proximal ends of the temperature sensor lead pairs 35, electrode sensing lead 96, transducer wires 93, 94 and the tip electrode condu ⁇ or wire 88 are gathered together and directed into the distal end of the inner lumen 97 of the catheter body 18.
  • the mounting stem 82 of the base 58 is pressed into the mounting hole 99 of the catheter body and fixedly securely thereto, for instance by an epoxy adhesive.
  • the proximal ends of the sensing lead pairs, tip ele ⁇ rode conductor wire, electrode sensing lead, and transducer wires 92 and 94 are conne ⁇ ed to an electrical conne ⁇ or of a manipulation handle (not shown) at the proximal end of the catheter body. They may be used for operative connection to temperature signal processing, mapping, and ultrasonic ablation operating systems.
  • the adhesive/sealant beads 102 and 104 provide a liquid seal that prevents blood and other fluids from reaching the underside of the piezoelectric transducer 24 and entering the inner lumen 97 of the catheter body 18. This also protects the various electrically condu ⁇ ive leads and wires conta ed within the catheter from sho ⁇ circuit by body fluids. Additionally, the adhesive rings electrically insulate the electrode band 26, transducer 24 and tip electrode 22 from each other to prevent sho ⁇ circuiting.
  • the transducer 24 is a piezoelectric transducer having a generally cylindrical shape.
  • the cylindrical piezoelectric transducer 24 directs ultrasonic acoustic energy in a radial outward direction for side-fire operation.
  • the transducer 24 may take other forms, such as the end-fire configuration shown in FIG. 5.
  • a piezoelectric transducer 108 is formed in a different configuration. Some reentrant pathways may be located in positions where a side-fire catheter cannot reach. In such cases, an end-fire catheter configuration may be successfully used. Additionally, an end-fire catheter may also be used for more precise ablation procedures where thin but deep lesions are preferred.
  • the transducer 108 has a hollow cylindrical po ⁇ ion defining a mounting flange 110 and has an integral, generally hollow, convex-shaped tip to result in a bullet-shaped appearance.
  • the convex tip may be a paraboloid or a hemisphere or other shapes.
  • the transducer 108 is easier to mount to the tip of the catheter in comparison to previous designs having only a hemispherical-shaped transducer. Additionally, it can be more accurately and easily mounted on the distal tip because of the larger surface area of the mounting flange and the use of an O-ring 143. This larger surface area for mounting also provides a larger surface area for the application of an adhesive to attach the tip to the catheter shaft. Improved sealing of the inner volume of the transducer should result.
  • the outer diameter of the flange 110 of the piezoelectric transducer 108 is sized to conform to the outer diameter of the catheter body 18. As shown, the distal-most end of the hemispherical tip 112 of the transducer 108 is formed with an axially aligned sensor bore hole 114.
  • the sensor holes are formed by the ultrasonic machining technique described above.
  • the inner 116 and outer 118 surfaces of the transducer 108 are plated or coated with an electrically conductive coating (not shown), such as gold, silver, or nickel to provide transducer excitation electrodes.
  • a first transducer wire 120 is bonded to the metallic coating disposed on the outer surface 118 of the transducer at the proximal end of the mounting flange 110.
  • a second transducer wire 122 is bonded to the metallic coating disposed on the inner surface 116 of the tip 112 of the transducer.
  • the wires are bonded to the respective surfaces by electrically conductive solder or other means to provide electrical continuity.
  • Each of the transducer wires has an electrically insulative jacket (not shown) that insulates the respective wire along its length to prevent sho ⁇ circuiting.
  • the piezoelectric transducer 108 in this embodiment is constructed for mounting to the distal end 20 of the catheter body 18 through the use of a generally cylindrical mounting member or base 124.
  • the base has a distally projecting cylindrical mounting neck 126 formed at the proximal end thereof with a larger diameter abutment plate 128.
  • the mounting neck is of smaller diameter than the inner diameter of the transducer flange 110.
  • the outer diameter of the abutment plate 128 is sized to conform to the outer diameter of the catheter body 18.
  • the proximal end of the abutment plate is formed with an axially projecting mounting stem 130 sized for snug receipt within the mounting hole 99 at the distal end of the catheter body 18.
  • the base 124 is also formed with an axial through bore 132 sized substantially the same diameter as the central inner lumen 97 of the catheter body 18.
  • a transducer wire bore hole 134 is formed from the outer surface of the mounting neck to the through bore 132 for receipt of the first transducer wire 120 therein.
  • the base may be composed of an electrically insulative material such as VLTEM.
  • the temperature sensor lead pair 138 is directed through the inner lumen of the sheath (not shown) disposed within the axial sensor bore hole 114 of the convex transducer so that the lead pair is disposed within the inner volume of the transducer.
  • the thermocouple end of the lead pair is bonded within the axial sensor bore hole so that the thermocouple is disposed generally flush with the outer surface 118 of the transducer.
  • the thermocouple is bonded within the sensor bore hole using an appropriate adhesive sealant.
  • the adhesive is shaped into a raised mound having a rounded crown 140 slightly above the outer surface of the transducer, the periphery of the crown having a diameter greater that the diameter of the sensor bore hole 114.
  • the adhesive is cured to securely affix the thermocouple 136 in position in relation to the outer surface and the sensor bore hole of the transducer.
  • the crown 140 protects the temperature sensing device 136 from damage and prevents the thermocouple thereof and sensor lead 138 from being pulled inwardly through the sheath after assembly. Fu ⁇ hermore, the adhesive crown 140 permits mounting the thermocouple flush with the outer surface of the transducer and provides a liquid seal that prevents blood and other fluids that may come into contact with the distal end of the catheter from reaching the underside of the piezoelectric transducer 108 through the transducer bore hole 114.
  • the first transducer wire 120 is directed inwardly through the radial transducer wire bore 134 and the second transducer wire 122 and the temperature sensor lead 138 are gathered together and directed through the axial bore 132 of the mounting base 124.
  • O ring 143 is mounted on the base 124 to center and suppo ⁇ the transducer 108 when it is mounted on the base.
  • the proximal end of the mounting flange 110 of the transducer 108 is then disposed over the mounting neck 126 of the base 124.
  • the O ring assists in disposing the transducer in concentric alignment with the neck 126.
  • adhesive/sealant 144 is applied between the two as well as in the space 146 between the abutment plate 128 of the base and the mounting flange 110.
  • the adhesive/sealant conforms with the outer diameter of the flange 110.
  • the transducer wire bore 134 may also be filled with the adhesive/sealant 144.
  • the adhesive sealant 144 is of a low durometer, biocompatible polymer that securely affixes the transducer to the mounting neck 126 of the base and has sufficient vibrational isolating and electrical insulating characteristics.
  • the adhesive sealant seals the interior of the catheter body 18 from the entry of bodily fluids that may cause undesirable transducer damping or possible sho ⁇ circuiting.
  • the respective transducer wires 120 and 122 and the temperature sensor lead 138 are then directed through the inner lumen 97 of the catheter body 18 to the proximal end of the catheter.
  • the mounting stem 130 of the base is then pressed into the mounting hole 99 of the distal end 20 of the catheter body and affixed therein using an appropriate epoxy, for instance.
  • the proximal ends of the sensing leads 138 and transducer wires 120 and 122 are conne ⁇ ed to an ele ⁇ rical conne ⁇ or of a manipulation handle connector (not shown) for operative connection to a temperature measurement processing system and transducer operating system.
  • the adhesive 144 between the mounting flange 110 and the mounting neck 126 provides minimal damping at the hemispherical tip 112 of the transducer because no adhesive is in contact with the inner surface thereof to cause such damping.
  • FIG. 6 a side-fire application of the catheter 10 illustrated in FIGS. 2, 3, and 4 is shown.
  • the distal tip 22 and band electrode 26 may be used for mapping purposes to locate an aberrant endocardial tissue site on the endocardial wall 16 of the hea ⁇ chamber.
  • the distal end 20 of the catheter 10 is positioned against the targeted endocardial site 16 in a parallel orientation as shown in FIG. 6 to perform an ablation procedure.
  • the distal end of the catheter is oriented such that one longitudinal side of the cylindrical piezoelectric transducer 24 contacts the target tissue site. In this orientation, the clinician may activate the piezoelectric transducer to ablate the target endocardial tissue adjacent the transducer.
  • the cylindrical transducer 24 When activated for ablation, the cylindrical transducer 24 radiates ultrasonic energy at a selected frequency radially outwardly to the endocardial wall 16 to ablate the target tissue. Because there are a plurality of temperature sensors 28 and they are located substantially at the outer surface of the cylindrical transducer, the temperature sensors are able to sense the temperature of the ablated tissue, adjacent flowing blood and the surface temperature of the transducer itself very rapidly. By monitoring sensor outputs or by processing them in other ways, the temperature of the ablation site may be determined. Referring now to FIG. 7 for an end-fire application, the catheter having the hemispherical transducer 108 at its distal tip is illustrated.
  • the hemispherical tip transducer 108 configuration may be useful in ce ⁇ ain applications where the aberrant target tissue is located at a position of the hea ⁇ chamber not conducive to use of the catheter having the cylindrical transducer 24 of FIG. 6. Due to the contours of the hea ⁇ chamber, the cylindrical transducer may be too large to fully contact the tissue along its longitudinal side and may therefore limit the cylindrical transducer's effectiveness.
  • the tip po ⁇ ion 112 of the convex transducer 108 and the distal tip temperature sensing device 136 are in contact with the target tissue of the endocardial wall 16. In this configuration, the tip transducer 108 is powered to ablate the target tissue.
  • the convex piezoelectric transducer 108 shown may result in a relatively thin but deep lesion. Because the temperature sensing device 136 is in direct contact with the ablated tissue site, a direct indication of the temperature thereof is provided and thus the operation of the transducer may be more precisely and accurately controlled to maintain the temperature within limits. In either of the catheter configurations shown in the figures, having the temperature sensing devices 28, 136 disposed in sensor bore holes 34, 114 formed in the piezoelectric transducer 24, 108 itself provides a desirable temperature sensing configuration. Because the thermocouple of the sensing device is disposed at the periphery of the transducer, a more accurate and faster temperature sensing response is provided.
  • the temperature sensing devices 28 offer a more rapid temperature sensing response indication of the endocardial ablation site and the flowing blood adjacent the ablation electrode so that ablation procedures can be more accurately and positively controlled.
  • the mounting means and adhesive/sealant configurations between the distal end of the catheter body and the pa ⁇ icular piezoelectric transducer provide a secure mounting arrangement while preventing undesirable leakage of bodily fluids into the catheter body as well as reduced damping of the transducer.
  • the target tissue is heated, and the resulting heat buildup in the transducer can impair transducer operation. Because of its mass, the target tissue has a greater thermal ine ⁇ ia than the transducer itself. Thus, when power is discontinued to the transducer, its temperature will decrease faster than the temperature of the target tissue. Additionally, at least a pa ⁇ of the transducer is located in the cooler flowing blood that will carry away some of the heat of the transducer.
  • the power to the transducer can be reduced or even shut off, the transducer can be allowed to cool, and the power can be increased or resumed to the transducer before the temperature of the target tissue decreases to any substantial degree.
  • steps can be accomplished by controlling the drive level of the power generator supplying ablation power to the transducer, as is discussed below in more detail.
  • FIG. 8 is a representative diagram showing frequency versus power transfer for three ultrasonic transducers RI, R2, and R3. Each transducer has a characteristic frequency or frequencies.
  • the first transducer Rj has a relatively high frequency sensitivity (Q).
  • Q frequency sensitivity
  • the series resonant frequency f s and parallel resonant frequency f both of which are characteristic frequencies of this transducer, occur where the power transfer is maximum in this case.
  • the power transfer drops off rapidly to either side of the resonant frequencies as well as in between the resonant frequencies.
  • the center frequency f c the power transfer is greatly decreased from both that of the series and parallel resonance frequencies.
  • a transducer having a bio-compatible outer layer that greatly reduces frequency sensitivity (lower Q) is represented by the line R 3 .
  • the power transfer is maximum at an operating frequency f c between the series resonant frequency f s and parallel resonant frequency f p and is actually greater than at frequencies f s and f p , with the power transfer tapering off beyond the region between the series and parallel resonant frequencies. In this case, power transfer is greatest at the frequency f c midway between the series and parallel resonance frequencies.
  • the series resonant frequency f s and parallel resonant frequency f p will typically drift to some extent, depending on the load appUed to the transducer and heat experienced.
  • a shift in the resonant frequencies results in a change in the power transfer curve.
  • the downward shift in the resonant frequencies causes the frequency v. power transfer curves of FIG. 8 to shift to the left, as shown by FIG. 9.
  • transducer R ⁇ which has a high frequency sensitivity, experiences a substantial change in power transfer when the resonance frequencies shift. If the frequency of energy driving the transducer were maintained at either of the initial resonant frequencies f s or f p , the power transfer would substantially decrease when the resonance frequencies s ⁇ ft downward to f s ' and f p '. Transducer R 2 also experiences a change in power transfer, although the change is not as great as the change experienced by transducer R,.
  • the bio-layer coating 27 is added to the exterior of the ultrasonic crystal to control the frequency sensitivity and achieve results similar to the transducer R3 shown in FIG. 9.
  • the bio-layer was selected to be 0.03 mm (0.0012 in.) thick. It was found that with a bio-layer of this thickness, an insignificant power transfer change occurred when the operational frequency f c of the ultrasonic crystal was determined with the ultrasonic crystal at 37° C and then the crystal was elevated in temperature to 85° C during an ablation procedure. This bio-layer effectively broadens the bandwidth of the R3 crystal by making it operational over a wider temperature range. As is seen in FIG. 9, the frequency range at which the response varies by an insignificant amount is much broader for R3 than for Rl or R2.
  • the bio-layer formed on the external surface of the ultrasonic transducer makes the transducer more durable and less subject to breakage when subjected to shocks during handling.
  • the bio-layer was formed of 353 ND epoxy made by Epoxy Technologies. The mechanical strength of the crystal is enhanced by the bio-layer with the crystal now being much more robust and can withstand larger impacts without shattering. It was also found that the mentioned epoxy had an acceptable thermal coefficient and transferred heat along the layer at an acceptable rate.
  • the power output line 172 carries the power output from the power control 174 to the transducer 24 at the distal end of the catheter 10 to provide the energy needed for ablation.
  • the temperature input line 176 carries temperature sensor signals from the temperature sensors located at the distal end of the catheter. These temperature sensor signals are processed in the temperature sensor processor 178 which outputs a temperature signal representing the temperature sensed to the control processor 182 through an analog-to-digital (“A/D") convener 180.
  • A/D analog-to-digital
  • the power generator 170 preferably generates a power output having a sine wave.
  • the power controller preferably includes a frequency synthesizer 184 that controls the frequency of the power output.
  • the control processor 182 controls the frequency synthesizer 184 as pa ⁇ of its control of the operation of the power control 174.
  • the power control 174 may include a power amplifier 186 in order to produce the power output 172 needed to be delivered to the catheter 10 for ablation.
  • the power supply 188 provides power to the various elements of the power generator 170.
  • a power transfer sensor such as the voltage and current monitor 190, monitors the voltage and current of the ablation energy to determine the impedance presented by the ultrasonic crystal 24.
  • the voltage and current monitor 190 provides signals representing the voltage and current values through an .A/D convener 192 to the control processor 182.
  • the control processor 182 controls the frequency synthesizer to alter the frequency driving the ultrasonic crystal 24 until the series and parallel resonant impedance frequencies have been found.
  • control processor 182 automatically causes the frequency synthesizer 184 to sweep through a predetermined frequency range to identify the resonance frequencies of the ultrasonic transducer 24 in response to actuation of the power-on or power application switch 185. At these frequencies, the impedance will be the lowest indicating that maximum power transfer is occurring.
  • the control processor 182 then calculates the average of the series and parallel resonance frequencies and controls the frequency synthesizer 184 to operate at the calculated average frequency. Specifically in one embodiment, the voltage is held constant as the frequency is swept.
  • the current monitor 190 monitors the current flow to the ultrasonic transducer 24 and provides a current level signal to the processor 182 through the A/D convener 192.
  • the highest current flow indicates the lowest impedance of the ultrasonic transducer.
  • the frequency at which the highest current flow occurs is the series resonance frequency.
  • the lowest current flow indicates the highest impedance of the ultrasonic transducer.
  • the frequency at which the lowest current flow occurs is the parallel resonance frequency. .As states above, the processor 182 averages the series and parallel resonance frequencies to arrive at the operating frequency.
  • this frequency sweep and operating frequency lock-on procedure was completed in less than one second.
  • a high impedance of 200 ⁇ was observed with some crystals and a low impedance of 40-50 ⁇ was observed.
  • An average operating impedance was observed to be 70-80 ⁇ .
  • the control processor 182 controls the power control 174 to apply power to the transducer 24 at a constant frequency while altering the drive level to maintain the temperature at the transducer within a predetermined range or level.
  • FIG. 11 is a flow cha ⁇ illustrating the operation of an energy delivery method in accordance with aspe ⁇ s of the present invention.
  • the catheter having an ultrasonic transducer is introduced into the patient and located at the site where energy is to be delivered. Such may occur for an ablation procedure.
  • the ultrasonic crystal may have stabilized at patient temperature, such as 37° C.
  • the lead for the ultrasonic crystal is plugged into the power generator 170 (FIG. 10) and the physician then causes the power generator to be placed in the "power on" mode 200.
  • the control processor causes the frequency synthesizer to sweep through a range of frequencies to locate the series resonant frequency and the parallel resonant frequency automatically 202.
  • the control processor then averages the two frequencies to determine a center frequency 204.
  • the operational frequency of the instrument is set at the center frequency 206 at which time a predetermined level of power is automatically applied to the transducer for performing the energy delivery process.
  • the above process is transparent to the user of the system. Pressing the power-on switch causes the system to automatically tune the power to the pa ⁇ icular ultrasonic crystal in use at the pa ⁇ icular patient temperature to which it has stabilized and then once the tuning is completed, automatically apply power to perform the energy delivery to the patient site.
  • the method and system therefore accurately tune the driving frequency for each crystal and for each energy delivery process.
  • the automatic tuning process took less than one second.
  • a temperature sensor such as the temperature sensor 28 shown in FIG. 3, is used to sense the temperature at the distal end of the catheter, and the sensed temperature is monitored at step 208 to control the drive level.
  • the drive level of the power output is decreased 212 to allow the transducer to cool down.
  • the drive level is increased 216 to a higher level to apply more power to the ablation site.
  • the first and second temperatures may be identical or the second temperature may be below the first by some amount, depending on the desired temperature sensitivity.
  • the operating frequency is maintained constant at the center frequency established in step 106. Controlling the drive level as shown in FIG. 11 permits control over the temperature so that tissue charring and blood boiling can be avoided.
  • the above method specifically mentions sweeping and tuning the drive frequency at only one time, after introduction to the patient and when at the patient energy delivery site.
  • the automatic tuning process can be condu ⁇ ed at other times also. For example, it may be automatically conducted while energy is being delivered.
  • the control processor may automatically and periodically sweep the frequencies to determine the optimum operating for the crystal at any time, including when the appHcation of power by the ultrasonic crystal has raised the site temperature to 85° C or higher. This operation was not selected in the previously-discussed embodiment because it was found that with the bio-layer, even though the optimum operating frequency changed with temperature, there was so little loss of power transfer that it was deemed to be not necessary to re-tune or recalibrate the crystal. However, such periodic re-tuning or reca ⁇ bration would be possible with the system and method presented above.
  • the above embodiment has specifically mentioned the use of the average of the series and parallel frequencies as the operating frequency.
  • a different operating frequency may be selected based on these detected frequencies or another detected frequency or frequencies.
  • the tuning system may be used to locate either the series or parallel frequency and operate at one of those frequencies or at a frequency that may be determined by reference to them. This frequency location and selection may be automatic as described above.

Abstract

An energy delivery system and method control the frequency of the power driving an ultrasonic device (24) to achieve more efficient power delivery. During operation of the ultrasonic device to deliver power to a patient site (16), the system and method automatically sweep the drive power through a frequency range, locate the series and parallel resonance frequencies, calculate the average of those frequencies and lock the power generator at that average frequency to drive the crystal. This frequency sweep procedure occurs automatically when the ultrasonic crystal is located at the patient site and the power generator operator presses the power-on switch to apply power. The method of tuning the power generator thus occurs when the crystal is at the site temperature and is transparent to the operator. The application of an external bio-layer to the crystal increases its bandwidth and its robustness. Mounting a temperature sensor (28) or sensors at the crystal permits monitoring of the crystal temperature and allows drive level control over the power generator to control the temperature at the crystal.

Description

ULTRASONIC ENERGY DELIVERY SYSTEM .AND METHOD
The application is a continuation-in-part application of serial number 08/434,004, filed May 2, 1995. BACKGROUND
The invention relates generally to power control, and more particularly, to a system and method for the more efficient transfer of energy from an ultrasonic power delivery system to biological tissue.
Improper growth of or damage to the conductive tissue in the heaπ can interfere with the passage of regular electrical signals from the S-A and A-V nodes. Electrical signal irregularities resulting from such interference can disturb the normal rhythm of the heaπ and cause an abnormal rhythmic condition referred to as cardiac arrhythmia. Arrhythmia can be controlled in many cases by ablating the errant heaπ tissue.
Once the origination point for the arrhythmia has been located in the tissue, the physician may use an ablation procedure to destroy the tissue causing the arrhythmia in an attempt to remove the electrical signal irregularities and restore normal heaπ beat or at least an improved heaπ beat. Successful ablation of the conductive tissue at the arrhythmia initiation site usually terminates the arrhythmia or at least moderates the heaπ rhythm to acceptable levels. Electrophysiological ("EP") ablation is a procedure more often employed in terminating cardiac arrhythmia. This procedure typically involves applying sufficient energy to the interfering conductive tissue to ablate that tissue, thereby removing the irregular signal pathway.
The distal end of an EP catheter may include mapping electrodes for locating the arrhythmia initiation site as well as an ablation device for performing the ablation procedure on the interfering conductive tissue. In another case, different catheters may be used for mapping and for ablation. One type of device locatable at the distal end of a catheter for delivering ablation energy to biological tissue is an ultrasonic device, such as a piezoelectric transducer or crystal. The piezoelectric transducer, excited by electrical energy to oscillate at ultrasonic frequencies, impaπs acoustic energy to the target tissue thereby causing ablation. However, an ultrasonic device is effectively an electrical to ultrasonic transducer and must be driven properly by electrical energy for effective power transfer. Ultrasonic devices incorporating piezoelectric elements are in effect complex circuits that are a combination of resistance, capacitance, and inductance. In such systems, there are one or more frequencies where the total impedance of the circuit will appear purely resistive. These frequencies are referred to as resonant frequencies. For an electro-mechanical transducer such as a piezoelectric transducer comprising complex circuitry, it has been found that resonant frequencies occur in pairs of relatively closely-spaced frequencies where the impedance is resistive and the phase angle is zero. The first of these frequencies is the so-called series resonant impedance frequency, and the second is the so-called parallel resonant impedance frequency. Typically, the most efficient energy transfer occurs at a resonant frequency. Less energy is lost in the conversion of electrical to acoustic energy and less energy is lost as heat during radiation of the acoustic energy. However, it has been found that typically with ceramic piezoelectric transducers, energy transfer is optimal at a frequency midway between these closely-spaced resonant frequencies and the power factor approaches, or is, one. Depending on the frequency sensitivity, or "Q", of the paπicular transducer, energy transfer may be greatly reduced when the frequency of the electrical energy applied to the transducer varies from the optimum frequency.
Resonant frequencies can vary substantially between different transducers depending on their physical structure. Additionally, the resonant frequencies of a paπicular transducer can vary substantially depending on the loading on the transducer at the time. The environmental loading, such as the temperature to which the transducer is exposed, can cause a shift in the resonant frequencies as can changes in the tissue or contact loading on the transducer.
It has been noted that a significant change in the optimal frequency can occur in a transducer when it is first exposed to room temperature (20° C) and is then introduced to the patient at normal human temperature (37° C). Calibrating the transducer for the optimal frequency at room temperature thus may result in a frequency far different from the optimal frequency when the transducer is at patient body temperature. This may result in a much lower power factor, less efficient transfer of power to the body tissue, and the need for longer ablation times or increased input power to achieve the desired ablation. Longer ablation times and increased input power are both undesirable. The former is undesirable due to the increased trauma to the patient and the latter due to the increased risk of exposing the patient to higher power levels. Thus it would be desirable to be able to calibrate the transducer at the actual temperature of the site.
During an EP surgical procedure, both the environmental and contact loading on an ablation transducer can vary widely. When the ablation device contacts body tissue, such as interfering conductive tissue in the heaπ, the loading is increased. The loading varies as the tissue is ablated or otherwise modified during the procedure and the temperature rises. These variations in loaoϋng can cause corresponding variations in the transducer's resonant frequencies, thereby causing variations in the efficiency of power transfer. Therefore, it is preferable to have a lower "Q" transducer so that changes in the loading of the transducer during an EP procedure do not cause an unacceptable lowering of the power factor.
A common method of determining resonant frequency is to apply an alternating current to the transducer and compare the resulting phase angle between the voltage applied to the transducer and the current drawn by the transducer. The phase angle equals ninety degrees for purely inductive circuits and minus ninety degrees for purely capacitive circuits. The phase angle equals zero for purely resistive circuits, with the voltage and current being in phase with each other. A phase angle of zero also indicates a resonant frequency of the transducer. However, this method of determining the resonance frequency is undesirable because the instruments required to determine the phase angle between voltage and current are relatively expensive and are less effective at higher frequencies, such as at 10 mHz. Thus a more practical, but accurate, apparatus and method for determining the optimal operating frequency of a transducer while in vivo is desirable. Such apparatus and method should be accurate at higher frequencies as well as relatively inexpensive and simple to manufacture. Another consideration in the design of ablation devices is the size of the device used. The device must be small enough to be introduced percutaneously into a patient while at the same time, must be large enough to be mounted on a catheter shaft that has room within for the passage of electrical wires and fluid lumens, depending on the application. Making the ultrasonic crystal device too small and too thin results in a fragile device. Such crystals are inherently extremely hard due to their crystalline structure and many times will be damaged by rough treatment. In some cases, those handling a catheter with an ablation crystal mounted on its distal end may drop the distal end of the catheter subjecting the crystal to a sharp shock. If the crystal is too thin, it may crack thereby rendering it unusable. If the crystal is too thick, it will be difficult to introduce it into a patient.
Thus, a need exists to make the ultrasonic crystal smaller but less fragile and at the same time, keep the crystal biologically compatible. Also, the ablation device should have a reasonable coefficient of thermal conductivity so that heat reaching the device during an ablation procedure will be conducted rapidly by the device. Controlling the temperature at the ablation device is impoπant so that blood boiling and tissue coagulation on the device do not occur. Coagulated tissue on the ablation device can cause an over-loading condition and the crystal may actually cease its vibrations if such loading exceeds the device's limit. It would be desirable to put a temperature sensor in the ablation device to monitor the temperature of the device and control the energy provided to the device to hold the temperature within limits. However, if the ablation device does not conduct thermal energy at a rapid rate or uniformly, the device may be hotter in one area than in another. If the temperature sensor is placed in a lower temperature area, higher temperatures causing blood boiling and coagulation at another paπ of the device may not be detected early enough. Thus, providing a crystal with relatively rapid thermal conductivity, sensing the temperature at the crystal, and controlUng the energy supplied to the crystal for ablation are desirable. Hence, those skilled in the aπ have recognized a need for an energy delivery system and method that can provide improved energy delivery to biological tissue. Additionally, those skilled in the aπ have recognized a need for an energy delivery system and method that can determine the optimal operation frequency of a transducer in-vivo relatively inexpensively and simply. Also, those skilled in the aπ have recognized the need for a system and method that is relatively insensitive to resonant frequency changes in the transducer caused by loading changes during an EP procedure. Fuπhermore, those skilled in the aπ have recognized the need for an improved transducer that is less susceptible to breakage due to physical shocks, yet is small enough to be introduced .into a patient and which is large enough to house a temperature sensor or sensors. The present invention fulfills these needs and others. SUMMARY OF THE INVENTION Briefly and in general terms, the present invention provides a system and a method for applying acoustic energy to biological tissue, comprising a catheter having distal and proximal ends, an ultrasonic transducer that transduces electrical energy into acoustic energy, said transducer having first and second resonance frequencies, said transducer mounted at the distal end of the catheter, a temperature sensor mounted at the distal end of the catheter that senses temperature and provides a temperature sensing signal, a tuning system connected to the ultrasonic transducer providing electrical energy to the transducer and monitoring the transducer's response thereto to determine the first and second resonance frequencies of the transducer, said tuning system providing first and second resonance signals as a result of the determination, and a power supply that provides electrical energy to the ultrasonic transducer at a frequency that is halfway between the first and second resonance frequencies at a drive level dependent on the temperature sensed by the temperature sensor. In another aspect, the invention provides processing means for calculating a center frequency as an average of the first and second resonant frequencies. In yet more detailed aspects, there is provided a biologically-compatible, non-metallic layer mounted on the outside of the ultrasonic transducer that lowers the frequency sensitivity of the transducer. In a fuπher aspect related to temperature control, the processor decreases the power drive level when the temperature signal represents a temperature above a predetermined first threshold temperature. Additionally, the ultrasonic transducer is cylindrically shaped and the temperature sensor is mounted in the ultrasonic transducer.
In accordance with another aspect of the invention, the power supply comprises a power appHcation switch wherein the power supply automatically applies test power to the ultrasonic transducer to determine the first and second resonant frequencies and then applies full power as selected at the halfway frequency. Fuπhermore, the power supply automatically sweeps through a predetermined range of frequencies to determine the first and second resonant frequencies. In yet another aspect, the power supply system holds the frequency constant while varying the power level to maintain the temperature within a predetermined range. Other aspects and advantages of the invention will become apparent from the following detailed description and accompanying drawings, illustrating by way of example the features of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a diagrammatic view of a human heaπ in paπial cross section showing an electrophysiological catheter disposed internally and located so that one side of a "side-fire" energy transducer mounted at the catheter's distal end is against the endocardium for performing an electrophysiological procedure;
FIG. 2 is an enlarged, paπially broken, cross-sectional side view of the distal end of the EP ablation catheter shown in FIG. 1 including a piezo-electric side-fire transducer having a plurality of temperature sensing devices;
FIG. 3 is an enlarged sectional side view of one of the temperature sensing devices in FIG. 2 showing its mounting configuration in the catheter;
FIG. 4 is an exploded perspective view of the distal end of the EP catheter shown in FIG. 2;
FIG. 5 is an enlarged cross-sectional view of the distal end of another embodiment of an EP catheter in which an "end-fire" ultrasonic transducer is formed with a convex- shaped tip and also includes a temperature sensing device disposed in the transducer; FIG. 6 is a side view of the catheter of FIG. 2 showing its distal end disposed parallel to and in contact with an ablation site for "side-fire" use;
FIG. 7 is a side view of the catheter of FIG. 5 showing its distal end disposed perpendicularly to and in contact with an ablation site for "end-fire" use;
FIG. 8 is a diagram showing frequency versus power transfer for three ultrasonic transducers having different frequency sensitivities; FIG. 9 is a diagram showing shifted frequency versus power transfer curves for the three ultrasonic transducers of FIG. 8 that have undergone a temperature change; and
FIG. 10 is a schematic diagram illustrating an ultrasonic energy delivery system for controlling the drive level of an ablation device in accordance with the principles of the present invention; and
FIG. 11 is a flow chaπ illustrating a method for controlling the drive level in accordance with the present invention. DET.AILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In the following description, like reference numerals will be used to refer to like or corresponding elements in the different figures of the drawings. Referring now to FIG. 1 in more detail, an electrophysiology ("EP") type catheter 10 is shown inseπed into the right ventricle 12 of a human heaπ 14 for localized diagnosis or treatment of the endocardial tissue 16 thereof. The catheter includes, in this case, an elongated catheter tube or body 18 having a distal end 20 with an electrode 22 mounted at the distal tip, a cylindrical ultrasonic transducer 24, in this case a piezoelectric device, mounted proximal to the tip electrode, and a band electrode 26 mounted proximal to the piezoelectric transducer 24. The electrodes 22 and 26 and the piezoelectric transducer 24 may be individually or simultaneously actuated to perform various electrophysiological procedures. In FIG. 1, the distal end of the catheter is shown parallel to and in contact with the endocardium for performing a "side-fire" EP ablation procedure with the piezoelectric transducer 24. As used herein, a "side-fire" device is one that is mounted such that it conducts energy sideways in relation to the catheter shaft. This would include the transmission of energy in the radial direction. An "end-fire" device is one that is mounted such that is conducts energy at the distal end of the catheter in relation to the catheter shaft. This would include the transmission of energy in the axial direction. The distal end 20 of the elongated catheter body 18 is steerable and has sufficient torsional and axial rigidity for maneuvering the distal end through the vascular system and to selected sites within the heaπ chamber. The catheter body 18' is of sufficient length, for instance to allow for a transluminal percutaneous brachial approach to the heaπ of an adult patient and/or a transluminal percutaneous femoral approach. Referring now in more detail to FIG. 2, the distal tip electrode 22 may be a mapping type electrode used to send or receive electrical signals from adjacent endocardial tissue for locating aberrant conductive tissues. Suitable materials for the tip electrode 22 include pure platinum, a platinum iridium alloy such as "platinum 10 iridium" (90% platinum 10% iridium), a gold alloy, pure titanium, and/or pure tungsten. The band electrode 26, located proximal to the piezoelectric transducer 24, may also be used either individually or simultaneously with the tip electrode 22 to perform EP mapping procedures. The cylindrical piezoelectric transducer 24 directs ultrasonic acoustic energy in a radial outward direction for "side-fire" operation. When transmitting ultrasonic energy radially outward, tissue located adjacent the transducer will be ablated.
During an ablation procedure, the piezo-electric transducer or crystal 24 may be subject to overheating if precautions are not taken to control heat buildup. Heat buildup can be prevented by maximizing heat transfer away from the crystal 24. In one embodiment, silver is desired as the outer coating on the crystal. Silver is one of the most thermally conductive materials available, so heat created by ablating the patient is rapidly conducted into the blood flow. However, silver is not as bio-compatible as other materials.
The silver can be coated with gold, which is bio-compatible, but the crystal would be rendered more fragile. In the embocliment shown, the transducer has an exterior coating comprising a biologically-compatible, non-metallic layer 27 mounted on the outside of the ultrasonic transducer. The non-metallic layer 27 serves to protect and strengthen the crystal as well as lowering the frequency sensitivity of the ultrasonic transducer. The thickness of the bio-layer in one embodiment was selected so that the section of catheter having the bio-layer had the same outer diameter as the section of the catheter proximal to the bio-layer.
As shown in FIG. 2, a pair of temperature sensing devices 28 are mounted in the wall of the cylindrical piezoelectric transducer 24. For purposes of illustration, two sensing devices are shown; however, more or fewer sensing devices may be mounted in the transducer. In one paπicular embodiment, three temperature sensing devices are mounted in the transducer wall and are spaced equi-angularly apaπ (120 degrees) in a common transverse plane. As is discussed below, having a greater number of temperature sensing devices in the transducer may be more desirable to obtain an accurate temperature indication in a side-fire application.
The cylindrical transducer 24 has inner 30 and outer surfaces 32 and sensor bore holes 34 are formed completely through those surfaces and the wall 33 of the transducer. Each of the sensing devices 28 is in the form of a point sensor mounted within the respective sensor bore hole.
The bore holes 34 may be formed through the wall of the cylindrical piezoelectric transducer by a non-mechanical contact, ultrasonic machining process available commercially. The bore holes, in one embodiment were 0.1778 mm (0.007 in.) in diameter. It is desirable that the temperature sensing devices 28 be as small as possible so that when the devices are mounted in the sensor bore holes of the piezoelectric transducer 24, the transducer's ultrasonic performance is minimally affected and the temperature response times are minimized.
Referring now to FIG. 3, thermocouples 33 used as the temperature sensing device 28 are shown. The thermocouple includes an elongated electrical sensing lead pair 35 comprising individually insulated flexible electrical temperature sensing leads 36 and 38. The electrical leads include respective electrically conductive wires, 40 and 42, formed of dissimilar materials. The distal poπion of each wire is stripped of its insulation 44 and is coupled with the stripped distal poπion of the other lead to form the thermocouple. In one embodiment, one wire 40 is formed of copper and the other wire 42 is formed of constantan ("T" type). Alternatively, the thermocouple 33 may be constructed of other dissimilar metallic materials. The distal poπions of the dissimilar wires 40 and 42 may be joined such as by welding or bonding together, for instance by conduαive solder 46, to form the thermocouple junction along the length of the solder joint. The electrical temperature sensing leads 36 and 38 are formed from a forty-four gauge (AWG) bifilar wire. A bifilar wire of this soπ is available from Hudson International of Trenton, Georgia and when conneαed as shown, it forms a T-type thermocouple 33. .Alternatively, the dissimilar metallic wires may be joined by TIG or laser welding to form an enlarged weld bead defining the thermocouple junαion.
In both configurations, electrical current may thus pass through the thermocouple junction to create the thermocouple effeα. The opposite ends of the respective sensing leads 36 and 38 may be conneαed to a conneαor (not shown) mounted on a manipulation handle at the proximal end of the catheter. The sensing leads carry the sensing signals responsive to the temperature sensed at the thermocouple. Those sensing signals may be used by monitoring equipment to derive temperature indications.
In the embodiment shown in FIG. 3, the sensor bore hole 34 is of a -uniform diameter along its length. In this embodiment, a flejcible elastomeric tubular sheath 48 is provided for receipt within the sensor bore hole, the sheath having an inner bore 50 therethrough. Preferably, the tubular sheath is composed of an elastomeric polyamide having an inner bore 50 diameter sized for snug receipt of the pair of electric sensor leads 36 and 38 and having an outer diameter sized for a snug fit within the sensor bore hole 34.
To assemble the temperature sensing device 28 to the transducer 24 in the embodiment shown in FIG. 3, the sheath 48 is pulled into the sensor bore hole 34 from the outside surface 32 of the transducer. The length of the sheath is greater than the thickness of the wall of the transducer and the non-metallic layer 27 so that an excess length protrudes inwardly from the inner surface 30 of the transducer. The outer surface of the sheath is cut or otherwise positioned such that it is flush with the outer surface of the non-metallic layer 27. An annular bead 52 of an adhesive, such as cyanoacrylate, is applied around the periphery of the sheath along the inner surface of the transducer to secure the sheath thereto. Not only does this bead 52 anchor the sheath in the bore, but it also provides an inner fluid seal to fuπher prevent the entry of body fluids into the interior of the catheter. The proximal ends of the bifilar sensor leads 36 and 38 are then received through the inner bore 50 of the sheath 48 from the outside of the transducer such that the distal extremity of the thermocouple 33 is positioned substantially at the same level or flush with the outer surface of the non-metallic layer 27 as shown in FIG. 3. Because the sheath extends inwardly past the edge of the bore 34, it provides a strain relief for the sensing thermocouple leads 36 and 38 as well as protecting them from the possible loss of their insulation layers 44 should they scrape against the transducer 24. Movement of the transducer 24 occurs due to the nature of a piezoeleαric transducer and such movement can be detrimental to sensor leads.
Thereafter, an adhesive 51 is applied to the thermocouple, sheath, and non- metallic coating 27 to seal and anchor the assembly as one as shown in FIG. 3. A crown allows the thermocouple to be mounted flush with the outer surface of the non-metallic coating 27. The non-metallic coating 27 provides a better acoustical impedance match between the piezoelectric crystal and heaπ tissue for more efficient energy transfer as discussed below in more detail. The coating 27 also provides a bio-layer and adds mechanical strength to the transducer.
As mentioned above, it has been found that piezoeleαric transducers will effect a pumping action of fluid through an associated orifice or opening due to the movement of the transducer. Fluid entry into the interior of an EP catheter is undesirable because it may significantly dampen the piezoelectric transducer's performance rendering the catheter effectively useless. The approach described above and illustrated in the accompanying figures prevents fluid entry. In the embodiment shown in FIG. 3, the use of a resilient sheath 48 compressed in the bore through the piezoelectric transducer 24 provides a first, main defense against leakage. By applying adhesive/sealant about the sheath on the outside and the inside provides fuπher protection against leakage as well as performing other functions described above.
With reference now to FIGS. 2 and 4, the construction of the distal end 20 of the catheter will be described including the assembly of the distal end electrode 22, the cylindrical piezoelectric transducer 24, and the band electrode 26 onto the distal end of the catheter. In general, the distal tip electrode 22, piezoelectric transducer 24, and band electrode 26 are mounted to a mounting member or base 58 and the base is mounted to the distal end of the catheter body 18. The mounting base 58 is generally an elongated cylindrical body having a longitudinal axial bore 60 therethrough. The distal end of the base has a head 62 formed with an annular O-ring retention groove 64. The base is formed with a smaller diameter neck 66 extending in the proximal direαion from the head 62 to a larger diameter flange 68 also formed with an annular O-ring retention groove 70. A radial sensor lead bore 72 is formed through the wall of the neck 66, generally at the medial poπion thereof. Formed proximally from the flange 68 is a larger diameter shoulder 74 having a flat surface 76 along one side. The flat surface 76 provides room for a welding joint of an electrical lead to the eleαrode, as discussed below. An eleαrode lead bore 78 is formed from the flat surface radially inwardly to the axial bore 60. The shoulder 74, from the proximal end thereof, uπher expands radially to a larger diameter abutment plate 80 and is formed therefrom with a smaller diameter elongated mounting stem 82 (shown paπially broken in FIG. 2). The base 58 is electrically insulative and may be formed of VLTEM for example.
The tip electrode 22, in the embodiment shown in FIGS. 2 and 4, is generally bullet-nose in shape but may take other shapes. The proximal end of the tip electrode 22 is formed with a small diameter, axially projeαing mounting post 84 in this embodiment. The proximal end of the post is formed with an axial electrode connector bore 86 for connection to an elongated electrical conductor wire 88 having an insulative jacket 90. The insulative jacket at the distal end of conductor wire 88 is stripped away and the distal tip of the wire conductor 88 is received within the connector bore 86. The conductor is affixed to the tip electrode by crimping the post 84 about the conductor or by soldering the conductor thereto, or by other means. The length of the conductor wire 88 is selected such that the conductor may extend and attach to an electrical connector at a manipulation handle (not shown) at the proximal end of the catheter 10. In the preferred configuration, the conductor wire is formed of a high strength copper beryllium that conducts electrical signals from the tip electrode to the connector at the proximal end of the catheter. In addition, the conductor wire acts as a safety chain to ensure that the tip assembly remains on the catheter shaft while being used in an EP procedure.
The piezoelectric transducer 24 has an outer diameter that is just slightly less than the catheter body 18 and the tip electrode 22 so that the diameter is the same when the non-metallic coating 27 is applied. The transducer 24 may be composed of a ceramic crystalline material. The outer 32 and inner 30 surfaces of the transducer have a thin film, electrically conduαive metaflic coating (not shown) such as gold, silver, or nickel disposed thereon to provide transducer excitation electrodes. A first electrically conductive transducer wire 92 is soldered to the metallic coating disposed on the outer surface 32 of the transducer at the proximal end thereof. A second eleαrically conductive transducer wire 94 is soldered to the metallic coating disposed on the inner surface 30 of the transducer at the distal end thereof. Each of the transducer wires has an eleαrically insulative jacket (not shown) that insulates the respeαive wires along their lengths to prevent shoπ circuiting. The band eleαrode 26 is generally a thin walled ring having an outer diameter substantially the same diameter as the catheter body 18, and the tip eleαrode 22. The inner diameter of the band is sized for mounting over the shoulder 74 of the base 58. The electrode band is electrically conductive and may be formed of platinum or gold or other materials. .An electrical sensor lead 96 is provided and has its distal end bonded to the inner surface of the band, for instance by soldering or weldment. The electrode sensor lead 96 has an electrically insulative jacket (not shown) that insulates the lead along its length. The catheter body 18 is formed with a longitudinal inner lumen 97 that extends the entire length of the body to its proximal end. The distal extremity of the catheter body is formed with an annular mounting hole 99 having an inner diameter sized for receipt of the mounting stem 84 of the base 58. When the distal end of the catheter 10 is assembled, the proximal end of the electrode sensor lead 96 of the electrode band 26 is passed inwardly through the electrode lead bore 78 of the base 58 and extended in a proximal direction out through the inner bore 60 thereof. The electrode band is thereafter assembled over the shoulder 74 of the base into contact with the abutment plate 80. The band is adhesively bonded to the shoulder, for instance using epoxy, to securely affix the band electrode to the base.
A pair of elastomeric O-rings 98 and 100 are provided to center the piezoelectric transducer 24 on the mounting base 58 at the catheter distal end and fix it in position. They also vibrationally isolate the piezoeleαric transducer 24 from the other components of the catheter 10. The first O-ring 98 is positioned in the second retainer groove 70 of the flange 68 at the proximal end of the neck 66. The second O-ring 100 is disposed within the first retainer groove 64 at the head 62 of the base.
The O-rings 98 and 100 may be composed of a low durometer material such as a silicone based polymer that provides sufficient high frequency vibration isolation characteristics while providing sufficient hardness such that the ultrasonic vibrations generated from the piezoeleαric transducer 24 are not unduly damped.
The piezoelectric transducer 24, having the temperature sensing devices 28 mounted thereto, is then mounted to the base 58. The first transducer wire 92 at the distal end of the transducer is received inwardly through the eleαrode lead bore 78 beneath the eleαrode band 26 and direαed in a proj imal direction through the inner bore 60 of the base. The second transducer wire 94 at the distal inner end of the transducer, along with the respeαive temperature sensor lead pairs 35 of the respective temperature sensing devices 28 are guided inwardly into the sensor lead bores 71 and 72 of the neck 66 of the base 58. The cylindrical transducer 24 is then mounted over the O-rings 98 and 100 and the neck of the base. The proximal end of the transducer is spaced a shoπ distance from the electrode band 26 and an electrically insulative spacer bead 102 (FIG. 2) of adhesive/sealant is appHed between the band 26, base 58, and transducer 24 to seal the space between the transducer 24 and the electrode band 26 and affix the transducer 24 in position. The adhesive/sealant is of a low durometer, bio- compatible adhesive/sealant and may be composed of a silicone-based polymer having sufficient vibrational isolating and electrical insulating characteristics. The proximal end of the tip conductor 88 of the tip electrode 22 is then received within the distal end of the inner axial bore 60 of the base 58 and the mounting post 84 of the tip electrode pressed into the distal end of the inner bore 60. .An adhesive, such as epoxy, bonds the mounting post within the inner bore 60 of the base. The proximal surface of the tip electrode is spaced a shoπ distance from the distal end of the piezoelectric transducer 24 and a second electrically insulative spacer bead 104 of adhesive/sealant is applied between the tip electrode 22, base 58, and transducer 24 to seal the space between the transducer and the tip electrode affixing the transducer in position. This adhesive/sealant is also a low durometer, bio-compatible material having sufficient vibrational isolating and eleαrical insulating characteristics. The combination of the two internal O-rings 98 and 100 and the two adhesive spacing and sealing beads 102 and 104 at either end of the piezoelectric transducer optimize the transfer of acoustic energy from the transducer to the tissue.
To complete the assembly of the distal end 20 of the catheter 10, the proximal ends of the temperature sensor lead pairs 35, electrode sensing lead 96, transducer wires 93, 94 and the tip electrode conduαor wire 88 are gathered together and directed into the distal end of the inner lumen 97 of the catheter body 18. The mounting stem 82 of the base 58 is pressed into the mounting hole 99 of the catheter body and fixedly securely thereto, for instance by an epoxy adhesive. The proximal ends of the sensing lead pairs, tip eleαrode conductor wire, electrode sensing lead, and transducer wires 92 and 94 are conneαed to an electrical conneαor of a manipulation handle (not shown) at the proximal end of the catheter body. They may be used for operative connection to temperature signal processing, mapping, and ultrasonic ablation operating systems.
The adhesive/sealant beads 102 and 104 provide a liquid seal that prevents blood and other fluids from reaching the underside of the piezoelectric transducer 24 and entering the inner lumen 97 of the catheter body 18. This also protects the various electrically conduαive leads and wires conta ed within the catheter from shoπ circuit by body fluids. Additionally, the adhesive rings electrically insulate the electrode band 26, transducer 24 and tip electrode 22 from each other to prevent shoπ circuiting.
In the embodiment shown in FIGS. 1, 2, 3, and 4, the transducer 24 is a piezoelectric transducer having a generally cylindrical shape. The cylindrical piezoelectric transducer 24 directs ultrasonic acoustic energy in a radial outward direction for side-fire operation. However, the transducer 24 may take other forms, such as the end-fire configuration shown in FIG. 5. In an alternative embodiment shown in FIG. 5, a piezoelectric transducer 108 is formed in a different configuration. Some reentrant pathways may be located in positions where a side-fire catheter cannot reach. In such cases, an end-fire catheter configuration may be successfully used. Additionally, an end-fire catheter may also be used for more precise ablation procedures where thin but deep lesions are preferred.
In this embodiment, the transducer 108 has a hollow cylindrical poπion defining a mounting flange 110 and has an integral, generally hollow, convex-shaped tip to result in a bullet-shaped appearance. The convex tip may be a paraboloid or a hemisphere or other shapes. By having the integral mounting flange 110 as shown, the transducer 108 is easier to mount to the tip of the catheter in comparison to previous designs having only a hemispherical-shaped transducer. Additionally, it can be more accurately and easily mounted on the distal tip because of the larger surface area of the mounting flange and the use of an O-ring 143. This larger surface area for mounting also provides a larger surface area for the application of an adhesive to attach the tip to the catheter shaft. Improved sealing of the inner volume of the transducer should result.
The outer diameter of the flange 110 of the piezoelectric transducer 108 is sized to conform to the outer diameter of the catheter body 18. As shown, the distal-most end of the hemispherical tip 112 of the transducer 108 is formed with an axially aligned sensor bore hole 114. The sensor holes are formed by the ultrasonic machining technique described above.
The inner 116 and outer 118 surfaces of the transducer 108 are plated or coated with an electrically conductive coating (not shown), such as gold, silver, or nickel to provide transducer excitation electrodes.
A first transducer wire 120 is bonded to the metallic coating disposed on the outer surface 118 of the transducer at the proximal end of the mounting flange 110. A second transducer wire 122 is bonded to the metallic coating disposed on the inner surface 116 of the tip 112 of the transducer. The wires are bonded to the respective surfaces by electrically conductive solder or other means to provide electrical continuity. Each of the transducer wires has an electrically insulative jacket (not shown) that insulates the respective wire along its length to prevent shoπ circuiting.
The piezoelectric transducer 108, in this embodiment is constructed for mounting to the distal end 20 of the catheter body 18 through the use of a generally cylindrical mounting member or base 124. In this embodiment, the base has a distally projecting cylindrical mounting neck 126 formed at the proximal end thereof with a larger diameter abutment plate 128. The mounting neck is of smaller diameter than the inner diameter of the transducer flange 110. The outer diameter of the abutment plate 128 is sized to conform to the outer diameter of the catheter body 18. The proximal end of the abutment plate is formed with an axially projecting mounting stem 130 sized for snug receipt within the mounting hole 99 at the distal end of the catheter body 18. The base 124 is also formed with an axial through bore 132 sized substantially the same diameter as the central inner lumen 97 of the catheter body 18. A transducer wire bore hole 134 is formed from the outer surface of the mounting neck to the through bore 132 for receipt of the first transducer wire 120 therein. The base may be composed of an electrically insulative material such as VLTEM. To assemble the convex piezoeleαric transducer 108 onto the distal end 20 of the catheter body 18, a thermocouple sensor 136 such as that shown in FIG. 3 is first formed as described above. The temperature sensor lead pair 138 is directed through the inner lumen of the sheath (not shown) disposed within the axial sensor bore hole 114 of the convex transducer so that the lead pair is disposed within the inner volume of the transducer. The thermocouple end of the lead pair is bonded within the axial sensor bore hole so that the thermocouple is disposed generally flush with the outer surface 118 of the transducer. The thermocouple is bonded within the sensor bore hole using an appropriate adhesive sealant. The adhesive is shaped into a raised mound having a rounded crown 140 slightly above the outer surface of the transducer, the periphery of the crown having a diameter greater that the diameter of the sensor bore hole 114. The adhesive is cured to securely affix the thermocouple 136 in position in relation to the outer surface and the sensor bore hole of the transducer. Once the adhesive is cured, the crown 140 protects the temperature sensing device 136 from damage and prevents the thermocouple thereof and sensor lead 138 from being pulled inwardly through the sheath after assembly. Fuπhermore, the adhesive crown 140 permits mounting the thermocouple flush with the outer surface of the transducer and provides a liquid seal that prevents blood and other fluids that may come into contact with the distal end of the catheter from reaching the underside of the piezoelectric transducer 108 through the transducer bore hole 114.
To fuπher assemble the hemispheric piezoelectric transducer 108 onto the distal end 20 of the catheter, the first transducer wire 120 is directed inwardly through the radial transducer wire bore 134 and the second transducer wire 122 and the temperature sensor lead 138 are gathered together and directed through the axial bore 132 of the mounting base 124. .An O ring 143 is mounted on the base 124 to center and suppoπ the transducer 108 when it is mounted on the base.
The proximal end of the mounting flange 110 of the transducer 108 is then disposed over the mounting neck 126 of the base 124. The O ring assists in disposing the transducer in concentric alignment with the neck 126. Because the inner diameter of the mounting flange is larger than the outer diameter of the mounting neck, adhesive/sealant 144 is applied between the two as well as in the space 146 between the abutment plate 128 of the base and the mounting flange 110. The adhesive/sealant conforms with the outer diameter of the flange 110. The transducer wire bore 134 may also be filled with the adhesive/sealant 144.
The adhesive sealant 144 is of a low durometer, biocompatible polymer that securely affixes the transducer to the mounting neck 126 of the base and has sufficient vibrational isolating and electrical insulating characteristics. The adhesive sealant seals the interior of the catheter body 18 from the entry of bodily fluids that may cause undesirable transducer damping or possible shoπ circuiting.
The respective transducer wires 120 and 122 and the temperature sensor lead 138 are then directed through the inner lumen 97 of the catheter body 18 to the proximal end of the catheter. The mounting stem 130 of the base is then pressed into the mounting hole 99 of the distal end 20 of the catheter body and affixed therein using an appropriate epoxy, for instance. The proximal ends of the sensing leads 138 and transducer wires 120 and 122 are conneαed to an eleαrical conneαor of a manipulation handle connector (not shown) for operative connection to a temperature measurement processing system and transducer operating system.
When the convex transducer 108 is in operation, the adhesive 144 between the mounting flange 110 and the mounting neck 126 provides minimal damping at the hemispherical tip 112 of the transducer because no adhesive is in contact with the inner surface thereof to cause such damping.
Referring to FIG. 6, a side-fire application of the catheter 10 illustrated in FIGS. 2, 3, and 4 is shown. The distal tip 22 and band electrode 26 may be used for mapping purposes to locate an aberrant endocardial tissue site on the endocardial wall 16 of the heaπ chamber. Once the site 16 has been targeted, the distal end 20 of the catheter 10 is positioned against the targeted endocardial site 16 in a parallel orientation as shown in FIG. 6 to perform an ablation procedure. For optimum ablation effectiveness, the distal end of the catheter is oriented such that one longitudinal side of the cylindrical piezoelectric transducer 24 contacts the target tissue site. In this orientation, the clinician may activate the piezoelectric transducer to ablate the target endocardial tissue adjacent the transducer.
When activated for ablation, the cylindrical transducer 24 radiates ultrasonic energy at a selected frequency radially outwardly to the endocardial wall 16 to ablate the target tissue. Because there are a plurality of temperature sensors 28 and they are located substantially at the outer surface of the cylindrical transducer, the temperature sensors are able to sense the temperature of the ablated tissue, adjacent flowing blood and the surface temperature of the transducer itself very rapidly. By monitoring sensor outputs or by processing them in other ways, the temperature of the ablation site may be determined. Referring now to FIG. 7 for an end-fire application, the catheter having the hemispherical transducer 108 at its distal tip is illustrated. The hemispherical tip transducer 108 configuration may be useful in ceπain applications where the aberrant target tissue is located at a position of the heaπ chamber not conducive to use of the catheter having the cylindrical transducer 24 of FIG. 6. Due to the contours of the heaπ chamber, the cylindrical transducer may be too large to fully contact the tissue along its longitudinal side and may therefore limit the cylindrical transducer's effectiveness. In the perpendicular orientation shown in FIG-. 7, the tip poπion 112 of the convex transducer 108 and the distal tip temperature sensing device 136 are in contact with the target tissue of the endocardial wall 16. In this configuration, the tip transducer 108 is powered to ablate the target tissue. The convex piezoelectric transducer 108 shown may result in a relatively thin but deep lesion. Because the temperature sensing device 136 is in direct contact with the ablated tissue site, a direct indication of the temperature thereof is provided and thus the operation of the transducer may be more precisely and accurately controlled to maintain the temperature within limits. In either of the catheter configurations shown in the figures, having the temperature sensing devices 28, 136 disposed in sensor bore holes 34, 114 formed in the piezoelectric transducer 24, 108 itself provides a desirable temperature sensing configuration. Because the thermocouple of the sensing device is disposed at the periphery of the transducer, a more accurate and faster temperature sensing response is provided. In addition, the chances of having a sensor in close proximity to the endocardial ablation site provides the clinician with a greater ability to control tissue and blood heating during the ablation procedure minimizing adverse effects to the patient. The temperature sensing devices 28 offer a more rapid temperature sensing response indication of the endocardial ablation site and the flowing blood adjacent the ablation electrode so that ablation procedures can be more accurately and positively controlled.
Fuπhermore, the mounting means and adhesive/sealant configurations between the distal end of the catheter body and the paπicular piezoelectric transducer provide a secure mounting arrangement while preventing undesirable leakage of bodily fluids into the catheter body as well as reduced damping of the transducer. During the ablation procedure, the target tissue is heated, and the resulting heat buildup in the transducer can impair transducer operation. Because of its mass, the target tissue has a greater thermal ineπia than the transducer itself. Thus, when power is discontinued to the transducer, its temperature will decrease faster than the temperature of the target tissue. Additionally, at least a paπ of the transducer is located in the cooler flowing blood that will carry away some of the heat of the transducer. Thus the power to the transducer can be reduced or even shut off, the transducer can be allowed to cool, and the power can be increased or resumed to the transducer before the temperature of the target tissue decreases to any substantial degree. These steps can be accomplished by controlling the drive level of the power generator supplying ablation power to the transducer, as is discussed below in more detail.
FIG. 8 is a representative diagram showing frequency versus power transfer for three ultrasonic transducers RI, R2, and R3. Each transducer has a characteristic frequency or frequencies. The first transducer Rj has a relatively high frequency sensitivity (Q). The series resonant frequency fs and parallel resonant frequency f , both of which are characteristic frequencies of this transducer, occur where the power transfer is maximum in this case. The power transfer drops off rapidly to either side of the resonant frequencies as well as in between the resonant frequencies. At the center frequency fc, the power transfer is greatly decreased from both that of the series and parallel resonance frequencies.
For a transducer having a lower frequency sensitivity, such as that shown by R2, there are also two characteristic frequencies, the series resonant frequency fs and parallel resonant frequency fp and they still occur where the power transfer is maximum, but the power transfer does not vary as widely at frequencies between fs and fp. Power transfer still drops off sharply in the region below the series resonant frequency fs and in the region above the parallel resonant frequency fp. However, in the area between the series and parallel resonant frequencies fs and fp including the center frequency fc, the power transfer remains relatively high with only a slight dip at fc.
A transducer having a bio-compatible outer layer that greatly reduces frequency sensitivity (lower Q) is represented by the line R3. For R3, the power transfer is maximum at an operating frequency fc between the series resonant frequency fs and parallel resonant frequency fp and is actually greater than at frequencies fs and fp, with the power transfer tapering off beyond the region between the series and parallel resonant frequencies. In this case, power transfer is greatest at the frequency fc midway between the series and parallel resonance frequencies.
During the operation of the transducer when subjected to changing temperature and changing loading conditions, the series resonant frequency fs and parallel resonant frequency fp will typically drift to some extent, depending on the load appUed to the transducer and heat experienced. A shift in the resonant frequencies results in a change in the power transfer curve. For example, the downward shift in the resonant frequencies causes the frequency v. power transfer curves of FIG. 8 to shift to the left, as shown by FIG. 9.
Depending on the paπicular transducer's frequency sensitivity, even a very small shift in the resonant frequencies (and hence in the power transfer curve) can cause a large change in power transfer. Referring now to FIG. 9, curves for transducers RI, R2, and R3 subjected to different loading conditions than in FIG. 8 are once again plotted on a graph of power transfer versus frequency. In this graph, the original series and parallel resonance frequencies fs and fp that are shown in FIG. 8 are now shown in dashed lines. The new series and parallel resonance frequencies fs' and fp' are shown and are at lower frequencies. FIG. 9 shows that transducer R^ which has a high frequency sensitivity, experiences a substantial change in power transfer when the resonance frequencies shift. If the frequency of energy driving the transducer were maintained at either of the initial resonant frequencies fs or fp, the power transfer would substantially decrease when the resonance frequencies s ύft downward to fs' and fp'. Transducer R2 also experiences a change in power transfer, although the change is not as great as the change experienced by transducer R,.
For the transducer R3 having an external bio-layer with resulting reduced frequency sensitivity, shifts in the series and parallel resonant frequencies to fs' and f . cause smaller variations in the power transfer curve for an operational frequency at fc and other frequencies lying between the series and parallel resonant frequencies. By setting and maintaining the operational frequency fc at a point midway between the original series f, and parallel fp frequencies, a small to moderate shift in the series fs and parallel fp resonant frequencies will result in a relatively minor change in the power transfer. The power transfer can be held relatively stable as the loading on the transducer changes.
Accordingly, the bio-layer coating 27 is added to the exterior of the ultrasonic crystal to control the frequency sensitivity and achieve results similar to the transducer R3 shown in FIG. 9. In one embodiment, the bio-layer was selected to be 0.03 mm (0.0012 in.) thick. It was found that with a bio-layer of this thickness, an insignificant power transfer change occurred when the operational frequency fc of the ultrasonic crystal was determined with the ultrasonic crystal at 37° C and then the crystal was elevated in temperature to 85° C during an ablation procedure. This bio-layer effectively broadens the bandwidth of the R3 crystal by making it operational over a wider temperature range. As is seen in FIG. 9, the frequency range at which the response varies by an insignificant amount is much broader for R3 than for Rl or R2. The responses for Rl and R2 have dropped much more than for R3. It was also noted that the bio-layer formed on the external surface of the ultrasonic transducer makes the transducer more durable and less subject to breakage when subjected to shocks during handling. In one embodiment, the bio-layer was formed of 353 ND epoxy made by Epoxy Technologies. The mechanical strength of the crystal is enhanced by the bio-layer with the crystal now being much more robust and can withstand larger impacts without shattering. It was also found that the mentioned epoxy had an acceptable thermal coefficient and transferred heat along the layer at an acceptable rate.
Referring now to FIG. 10, a block diagram of an embodiment of a power , generator 170 is presented. The power output line 172 carries the power output from the power control 174 to the transducer 24 at the distal end of the catheter 10 to provide the energy needed for ablation. The temperature input line 176 carries temperature sensor signals from the temperature sensors located at the distal end of the catheter. These temperature sensor signals are processed in the temperature sensor processor 178 which outputs a temperature signal representing the temperature sensed to the control processor 182 through an analog-to-digital ("A/D") convener 180.
The power generator 170 preferably generates a power output having a sine wave. The power controller preferably includes a frequency synthesizer 184 that controls the frequency of the power output. The control processor 182 controls the frequency synthesizer 184 as paπ of its control of the operation of the power control 174. The power control 174 may include a power amplifier 186 in order to produce the power output 172 needed to be delivered to the catheter 10 for ablation.
The power supply 188 provides power to the various elements of the power generator 170. A power transfer sensor, such as the voltage and current monitor 190, monitors the voltage and current of the ablation energy to determine the impedance presented by the ultrasonic crystal 24. The voltage and current monitor 190 provides signals representing the voltage and current values through an .A/D convener 192 to the control processor 182. The control processor 182 controls the frequency synthesizer to alter the frequency driving the ultrasonic crystal 24 until the series and parallel resonant impedance frequencies have been found.
In one embodiment, the control processor 182 automatically causes the frequency synthesizer 184 to sweep through a predetermined frequency range to identify the resonance frequencies of the ultrasonic transducer 24 in response to actuation of the power-on or power application switch 185. At these frequencies, the impedance will be the lowest indicating that maximum power transfer is occurring. The control processor 182 then calculates the average of the series and parallel resonance frequencies and controls the frequency synthesizer 184 to operate at the calculated average frequency. Specifically in one embodiment, the voltage is held constant as the frequency is swept. The current monitor 190 monitors the current flow to the ultrasonic transducer 24 and provides a current level signal to the processor 182 through the A/D convener 192. The highest current flow indicates the lowest impedance of the ultrasonic transducer. The frequency at which the highest current flow occurs is the series resonance frequency. The lowest current flow indicates the highest impedance of the ultrasonic transducer. The frequency at which the lowest current flow occurs is the parallel resonance frequency. .As states above, the processor 182 averages the series and parallel resonance frequencies to arrive at the operating frequency.
In one embodiment, this frequency sweep and operating frequency lock-on procedure was completed in less than one second. A high impedance of 200 Ω was observed with some crystals and a low impedance of 40-50 Ω was observed. An average operating impedance was observed to be 70-80 Ω. The control processor 182 controls the power control 174 to apply power to the transducer 24 at a constant frequency while altering the drive level to maintain the temperature at the transducer within a predetermined range or level.
FIG. 11 is a flow chaπ illustrating the operation of an energy delivery method in accordance with aspeαs of the present invention. The catheter having an ultrasonic transducer is introduced into the patient and located at the site where energy is to be delivered. Such may occur for an ablation procedure. During this introduction procedure, the ultrasonic crystal may have stabilized at patient temperature, such as 37° C. The lead for the ultrasonic crystal is plugged into the power generator 170 (FIG. 10) and the physician then causes the power generator to be placed in the "power on" mode 200. The control processor causes the frequency synthesizer to sweep through a range of frequencies to locate the series resonant frequency and the parallel resonant frequency automatically 202. The control processor then averages the two frequencies to determine a center frequency 204. The operational frequency of the instrument is set at the center frequency 206 at which time a predetermined level of power is automatically applied to the transducer for performing the energy delivery process.
The above process is transparent to the user of the system. Pressing the power-on switch causes the system to automatically tune the power to the paπicular ultrasonic crystal in use at the paπicular patient temperature to which it has stabilized and then once the tuning is completed, automatically apply power to perform the energy delivery to the patient site. The method and system therefore accurately tune the driving frequency for each crystal and for each energy delivery process. As mentioned above, in one case, the automatic tuning process took less than one second.
A temperature sensor, such as the temperature sensor 28 shown in FIG. 3, is used to sense the temperature at the distal end of the catheter, and the sensed temperature is monitored at step 208 to control the drive level. When the temperature is determined to be above a first seleαed temperature, such as 85° C 210, the drive level of the power output is decreased 212 to allow the transducer to cool down. If the temperature is determined to be below a second selected temperature 214, the drive level is increased 216 to a higher level to apply more power to the ablation site. The first and second temperatures may be identical or the second temperature may be below the first by some amount, depending on the desired temperature sensitivity.
During the procedure shown in FIG. 11, the operating frequency is maintained constant at the center frequency established in step 106. Controlling the drive level as shown in FIG. 11 permits control over the temperature so that tissue charring and blood boiling can be avoided.
The above method specifically mentions sweeping and tuning the drive frequency at only one time, after introduction to the patient and when at the patient energy delivery site. However, the automatic tuning process can be conduαed at other times also. For example, it may be automatically conducted while energy is being delivered. The control processor may automatically and periodically sweep the frequencies to determine the optimum operating for the crystal at any time, including when the appHcation of power by the ultrasonic crystal has raised the site temperature to 85° C or higher. This operation was not selected in the previously-discussed embodiment because it was found that with the bio-layer, even though the optimum operating frequency changed with temperature, there was so little loss of power transfer that it was deemed to be not necessary to re-tune or recalibrate the crystal. However, such periodic re-tuning or recaϋbration would be possible with the system and method presented above.
Additionally, the above embodiment has specifically mentioned the use of the average of the series and parallel frequencies as the operating frequency. However, a different operating frequency may be selected based on these detected frequencies or another detected frequency or frequencies. For example, where a higher Q crystal is needed for a paπicular application, the tuning system may be used to locate either the series or parallel frequency and operate at one of those frequencies or at a frequency that may be determined by reference to them. This frequency location and selection may be automatic as described above.
Although preferred and alternative embodiments of the invention have been described and illustrated, the invention is susceptible to modifications and adaptations within the ability of those skilled in the aπ and without the exercise of inventive faculty. Thus, it should be understood that various changes in form, detail, and usage of the present invention may be made without depaπing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims

CLAIMS What is claimed is:
1. A system for delivering energy to biological tissue, comprising: a catheter having distal and proximal ends; an ultrasonic transducer adapted to transduce electrical energy into acoustic energy, the transducer having a characteristic frequency, the transducer mounted at the distal end of the catheter; a power supply that provides electrical energy to the ultrasonic transducer at a selectable frequency; a power transfer sensor coupled to the ultrasonic transducer that measures the response of the ultrasonic transducer to the power provided to it by the power supply, the sensor providing a power transfer signal; a processor adapted to automatically control the power supply to vary the frequency of electrical energy applied to the transducer and to monitor the power transfer signal in response to the frequency variation to determine the characteristic frequency of the transducer.
2. The system of claim 1 wherein the processor automatically controls the power supply to sweep through a predetermined range of frequencies while monitoring the power transfer signal to determine the characteristic frequency.
3. The system of claim 2 wherein the processor automatically controls the power supply to operate at the determined characteristic frequency.
4. The system of claim 2 wherein the processor is adapted to automatically process the determined characteristic frequency to derive an operation frequency therefrom and automatically control the power supply to operate at the operation frequency.
5. The system of claim 1 wherein the tuning system automatically controls the power supply to sweep through a predetermined range of frequencies while monitoring the power transfer signal to determine first and second resonance frequencies of the ultrasonic transducer.
6. The system of claim 5 wherein the processor automatically controls the power supply to operate at or near one of the determined resonance frequencies.
7. The system of claim 5 wherein the tuning system automatically processes the determined resonance frequencies to derive an operation frequency therefrom and automatically controls the power supply to operate at the operation frequency.
8. The system of claim 7 wherein the processor automatically averages the first and second resonance frequencies and automatically controls the power supply to operate at the average frequency.
9. The system of claim 8 fuπher comprising a power application switch; wherein the processor is responsive to actuation of the power application switch to automatically control the power supply to apply power to the ultrasonic transducer while varying the frequency to determine the first and second resonant frequencies while monitoring the power transfer signal and to then apply a predetermined level of power as selected at the operation frequency.
10. The system of claim 1 fuπher comprising a biologically-compatible layer formed on the outside of the ultrasonic transducer that lowers the frequency sensitivity of the transducer.
11. The system of claim 10 wherein the biologically-compatible layer is non- metallic and has a relatively high coefficient of thermal conduαivity.
12. The system of claim 1 fuπher comprising a temperature sensor mounted at the distal end of the catheter that senses temperature and provides a temperature sensing signal.
13. The system of claim 12 wherein the processor receives the temperature sensing signal, compares it to a predetermined first threshold temperature and controls the power supply to decrease the power drive level when the temperature signal represents a temperature above the first threshold.
14. The system of claim 13 wherein the processor automatically controls the power supply to hold the frequency constant while varying the power level to maintain the temperature within a predetermined range.
15. The system of claim 12 wherein the temperature sensor is mounted in the ultrasonic transducer.
16. The system of claim 15 wherein the ultrasonic transducer is cylindrically shaped.
17. A method of delivering energy to a biological site, comprising the steps of: applying electrical power to an ultrasonic transducer that is adapted to transduce electrical energy into acoustic energy, the transducer having a characteristic frequency; measuring the response of the ultrasonic transducer to the power provided to it, the sensor providing a power transfer signal; automatically varying the frequency of electrical energy applied to the transducer and monitoring the power transfer signal in response to the frequency variation to determine the characteristic frequency of the transducer.
18. The method of claim 17 wherein the step of varying the frequency comprises the step of automatically sweeping through a predetermined range of frequencies while monitoring the power transfer signal to determine the characteristic frequency.
19. The method of claim 18 comprising the fuπher step of automatically applying power to the transducer to operate at the determined characteristic frequency.
20. The method of claim 18 comprising the . fuπher step of automatically processing the determined characteristic frequency to derive an operation frequency therefrom and automatically applying power to the transducer at the derived operation frequency.
21. The method of claim 17 fuπher comprising the step of automatically sweeping through a predetermined range of frequencies while monitoring the power transfer signal to determine first and second resonance frequencies of the ultrasonic transducer.
22. The method of claim 21 comprising the fuπher step of automatically applying power to the transducer at or near one of the determined resonance frequencies.
23. The method of claim 21 comprising the fuπher step of automatically deriving an operation frequency from the determined resonance frequencies and automatically applying power to the transducer to operate at the operation frequency.
24. The method of claim 23 comprising the step of averaging the first and second resonance frequencies and automatically applying power to the transducer to operate at the average frequency.
25. The method of claim 24 fuπher comprising the steps of: actuating a power application switch; automatically applying power to the ultrasonic transducer while varying the frequency in response to actuation of the power application switch to determine the first and second resonant frequencies while monitoring the power transfer signal; and applying a predetermined level of power to the transducer at the operation frequency.
26. The method of claim 17 fuπher comprising the step of forming a biologically-compatible layer on the outside of the ultrasonic transducer that lowers the frequency sensitivity of the transducer.
27. The method of claim 26 wherein the step of forming the biologically- compatible layer comprising forming the layer of a non-metallic material that has a relatively high coefficient of thermal conductivity.
28. The method of claim 17 fuπher comprising the steps of sensing temperature at the distal end of the catheter and providing a temperature sensing signal.
29. The method of claim 28 fuπher comprising the steps of comparing the temperature sensing signal to a predetermined first threshold temperature; decreasing the power drive level to the transducer when the temperature signal represents a temperature above the first threshold.
30. The method of claim 28 fuπher comprising the step os automatically controlling the frequency to be constant while varying the power level to maintain the temperature within a predetermined range.
31. The method of claim 28 fuπher comprising the step of mounting the temperature sensor in the ultrasonic transducer.
32. The method of claim 31 comprising the step of forming the ultrasonic transducer to be cylindrical in shape.
PCT/US1997/015870 1996-09-09 1997-09-09 Ultrasonic energy delivery system and method WO1998011826A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP10514716A JP2000500059A (en) 1996-09-09 1997-09-09 Ultrasonic energy delivery device and method
EP97941463A EP0873082A4 (en) 1996-09-09 1997-09-09 Ultrasonic energy delivery system and method
AU43365/97A AU4336597A (en) 1996-09-09 1997-09-09 Ultrasonic energy delivery system and method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/708,829 US5735280A (en) 1995-05-02 1996-09-09 Ultrasound energy delivery system and method
US08/708,829 1996-09-09

Publications (1)

Publication Number Publication Date
WO1998011826A1 true WO1998011826A1 (en) 1998-03-26

Family

ID=24847341

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/015870 WO1998011826A1 (en) 1996-09-09 1997-09-09 Ultrasonic energy delivery system and method

Country Status (6)

Country Link
US (1) US5735280A (en)
EP (1) EP0873082A4 (en)
JP (1) JP2000500059A (en)
AU (1) AU4336597A (en)
CA (1) CA2236255A1 (en)
WO (1) WO1998011826A1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048711A1 (en) * 1997-05-01 1998-11-05 Ekos Corporation Ultrasound catheter
WO2000016704A1 (en) * 1998-09-24 2000-03-30 Ekos Corporation Ultrasound catheter for improving blood flow to the heart
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
WO2003051208A1 (en) * 2001-12-14 2003-06-26 Ekos Corporation Blood flow reestablishment determination
US6723063B1 (en) 1998-06-29 2004-04-20 Ekos Corporation Sheath for use with an ultrasound element
US8585685B2 (en) 2006-04-27 2013-11-19 Erbe Elektromedizin Gmbh Device for treatment of human or animal tissue by means of a magnetically movable instrument
US8690818B2 (en) 1997-05-01 2014-04-08 Ekos Corporation Ultrasound catheter for providing a therapeutic effect to a vessel of a body
US8852166B1 (en) 2002-04-01 2014-10-07 Ekos Corporation Ultrasonic catheter power control
CN104780858A (en) * 2012-11-06 2015-07-15 迈迪生医疗器械公司 Systems and methods for controlling delivery of ultrasonic energy to a bodily tissue
US9107590B2 (en) 2004-01-29 2015-08-18 Ekos Corporation Method and apparatus for detecting vascular conditions with a catheter
US9415242B2 (en) 2001-12-03 2016-08-16 Ekos Corporation Catheter with multiple ultrasound radiating members
US9713481B2 (en) 2012-10-16 2017-07-25 Med-Sonics Corporation Apparatus and methods for transferring ultrasonic energy to a bodily tissue
US10092742B2 (en) 2014-09-22 2018-10-09 Ekos Corporation Catheter system
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
US11458290B2 (en) 2011-05-11 2022-10-04 Ekos Corporation Ultrasound system
US11672553B2 (en) 2007-06-22 2023-06-13 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US11925367B2 (en) 2007-01-08 2024-03-12 Ekos Corporation Power parameters for ultrasonic catheter

Families Citing this family (242)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161543A (en) * 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US6099524A (en) * 1994-01-28 2000-08-08 Cardiac Pacemakers, Inc. Electrophysiological mapping and ablation catheter and method
US6409722B1 (en) 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US5897553A (en) 1995-11-02 1999-04-27 Medtronic, Inc. Ball point fluid-assisted electrocautery device
US6152899A (en) * 1996-03-05 2000-11-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
NL1003024C2 (en) * 1996-05-03 1997-11-06 Tjong Hauw Sie Stimulus conduction blocking instrument.
US5989274A (en) 1996-10-17 1999-11-23 Ethicon Endo-Surgery, Inc. Methods and devices for improving blood flow to a heart of a patient
US6719755B2 (en) * 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US6840936B2 (en) * 1996-10-22 2005-01-11 Epicor Medical, Inc. Methods and devices for ablation
US6311692B1 (en) * 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US20040260278A1 (en) * 1996-10-22 2004-12-23 Anderson Scott C. Apparatus and method for ablating tissue
US6805128B1 (en) 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US7052493B2 (en) * 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6997925B2 (en) * 1997-07-08 2006-02-14 Atrionx, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6245064B1 (en) 1997-07-08 2001-06-12 Atrionix, Inc. Circumferential ablation device assembly
US6117101A (en) 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6652515B1 (en) * 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
US6050943A (en) 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US8709007B2 (en) * 1997-10-15 2014-04-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Devices and methods for ablating cardiac tissue
US6259941B1 (en) * 1997-10-20 2001-07-10 Irvine Biomedical, Inc. Intravascular ultrasound locating system
US6246899B1 (en) * 1997-10-20 2001-06-12 Irvine Biomedical, Inc. Ultrasound locating system having ablation capabilities
US6233477B1 (en) * 1997-10-20 2001-05-15 Irvine Biomedical, Inc. Catheter system having controllable ultrasound locating means
DE69941252D1 (en) 1998-01-14 2009-09-24 Ams Res Corp RIBBED ELECTRODES
US6322583B1 (en) 1998-03-23 2001-11-27 Hosheng Tu Medical device and methods thereof
US6537248B2 (en) * 1998-07-07 2003-03-25 Medtronic, Inc. Helical needle apparatus for creating a virtual electrode used for the ablation of tissue
US6706039B2 (en) * 1998-07-07 2004-03-16 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US8308719B2 (en) * 1998-09-21 2012-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
US6245062B1 (en) * 1998-10-23 2001-06-12 Afx, Inc. Directional reflector shield assembly for a microwave ablation instrument
WO2000030554A1 (en) 1998-11-20 2000-06-02 Jones Joie P Methods for selectively dissolving and removing materials using ultra-high frequency ultrasound
US6607502B1 (en) 1998-11-25 2003-08-19 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US7194294B2 (en) * 1999-01-06 2007-03-20 Scimed Life Systems, Inc. Multi-functional medical catheter and methods of use
US6206831B1 (en) 1999-01-06 2001-03-27 Scimed Life Systems, Inc. Ultrasound-guided ablation catheter and methods of use
US6468271B1 (en) 1999-02-24 2002-10-22 Scimed Life Systems, Inc. Device and method for percutaneous myocardial revascularization
US6086821A (en) * 1999-03-29 2000-07-11 The United States Of America As Represented By The Secretary Of The Navy Ultrasonic force differentiation assay
ATE353001T1 (en) 1999-05-11 2007-02-15 Atrionix Inc BALLOON ANCHORING WIRE
US6758830B1 (en) 1999-05-11 2004-07-06 Atrionix, Inc. Catheter positioning system
US20070282324A1 (en) * 1999-07-19 2007-12-06 Matthias Vaska Apparatus and method for diagnosis and therapy of electrophysiological disease
CA2377583A1 (en) * 1999-07-19 2001-01-25 Epicor, Inc. Apparatus and method for ablating tissue
US6315732B1 (en) 1999-07-20 2001-11-13 Scimed Life Systems, Inc. Imaging catheter and methods of use for ultrasound-guided ablation
US6334859B1 (en) * 1999-07-26 2002-01-01 Zuli Holdings Ltd. Subcutaneous apparatus and subcutaneous method for treating bodily tissues with electricity or medicaments
US6692450B1 (en) 2000-01-19 2004-02-17 Medtronic Xomed, Inc. Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US6409720B1 (en) 2000-01-19 2002-06-25 Medtronic Xomed, Inc. Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US7706882B2 (en) 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
US8221402B2 (en) 2000-01-19 2012-07-17 Medtronic, Inc. Method for guiding a medical device
US6413254B1 (en) 2000-01-19 2002-07-02 Medtronic Xomed, Inc. Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6595934B1 (en) 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6361531B1 (en) 2000-01-21 2002-03-26 Medtronic Xomed, Inc. Focused ultrasound ablation devices having malleable handle shafts and methods of using the same
US8048070B2 (en) 2000-03-06 2011-11-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices, systems and methods
AU2001253654A1 (en) 2000-04-27 2001-11-12 Medtronic, Inc. Vibration sensitive ablation apparatus and method
US6514250B1 (en) * 2000-04-27 2003-02-04 Medtronic, Inc. Suction stabilized epicardial ablation devices
WO2001087169A1 (en) * 2000-05-16 2001-11-22 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
WO2001095820A1 (en) 2000-06-13 2001-12-20 Atrionix, Inc. Surgical ablation probe for forming a circumferential lesion
US6926669B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US7077853B2 (en) * 2000-10-20 2006-07-18 Ethicon Endo-Surgery, Inc. Method for calculating transducer capacitance to determine transducer temperature
US7914453B2 (en) 2000-12-28 2011-03-29 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US20040138621A1 (en) 2003-01-14 2004-07-15 Jahns Scott E. Devices and methods for interstitial injection of biologic agents into tissue
US6740040B1 (en) * 2001-01-30 2004-05-25 Advanced Cardiovascular Systems, Inc. Ultrasound energy driven intraventricular catheter to treat ischemia
US6743225B2 (en) 2001-03-27 2004-06-01 Uab Research Foundation Electrophysiologic measure of endpoints for ablation lesions created in fibrillating substrates
US7959626B2 (en) 2001-04-26 2011-06-14 Medtronic, Inc. Transmural ablation systems and methods
US6663627B2 (en) 2001-04-26 2003-12-16 Medtronic, Inc. Ablation system and method of use
US6648883B2 (en) * 2001-04-26 2003-11-18 Medtronic, Inc. Ablation system and method of use
US6807968B2 (en) 2001-04-26 2004-10-26 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US6699240B2 (en) * 2001-04-26 2004-03-02 Medtronic, Inc. Method and apparatus for tissue ablation
US7846096B2 (en) * 2001-05-29 2010-12-07 Ethicon Endo-Surgery, Inc. Method for monitoring of medical treatment using pulse-echo ultrasound
US7211044B2 (en) * 2001-05-29 2007-05-01 Ethicon Endo-Surgery, Inc. Method for mapping temperature rise using pulse-echo ultrasound
US20030092988A1 (en) * 2001-05-29 2003-05-15 Makin Inder Raj S. Staging medical treatment using ultrasound
JP4341907B2 (en) 2001-09-05 2009-10-14 セイリアント・サージカル・テクノロジーズ・インコーポレーテッド Fluid-assisted medical device, system and method
US6656175B2 (en) * 2001-12-11 2003-12-02 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US7211055B2 (en) 2002-01-15 2007-05-01 The Regents Of The University Of California System and method providing directional ultrasound therapy to skeletal joints
WO2003061756A2 (en) 2002-01-23 2003-07-31 The Regents Of The University Of California Implantable thermal treatment method and apparatus
US20080275439A1 (en) * 2002-01-25 2008-11-06 David Francischelli Cardiac ablation and electrical interface system and instrument
US7967816B2 (en) 2002-01-25 2011-06-28 Medtronic, Inc. Fluid-assisted electrosurgical instrument with shapeable electrode
US6827715B2 (en) * 2002-01-25 2004-12-07 Medtronic, Inc. System and method of performing an electrosurgical procedure
US7258674B2 (en) * 2002-02-20 2007-08-21 Liposonix, Inc. Ultrasonic treatment and imaging of adipose tissue
US6819027B2 (en) * 2002-03-04 2004-11-16 Cepheid Method and apparatus for controlling ultrasonic transducer
US7369115B2 (en) * 2002-04-25 2008-05-06 Immersion Corporation Haptic devices having multiple operational modes including at least one resonant mode
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US20040002740A1 (en) * 2002-05-08 2004-01-01 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7118566B2 (en) 2002-05-16 2006-10-10 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US7294143B2 (en) * 2002-05-16 2007-11-13 Medtronic, Inc. Device and method for ablation of cardiac tissue
US6786202B2 (en) * 2002-09-24 2004-09-07 Caterpillar Inc Hydraulic pump circuit
US7258690B2 (en) 2003-03-28 2007-08-21 Relievant Medsystems, Inc. Windowed thermal ablation probe
US6907884B2 (en) 2002-09-30 2005-06-21 Depay Acromed, Inc. Method of straddling an intraosseous nerve
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US8808284B2 (en) 2008-09-26 2014-08-19 Relievant Medsystems, Inc. Systems for navigating an instrument through bone
US8613744B2 (en) 2002-09-30 2013-12-24 Relievant Medsystems, Inc. Systems and methods for navigating an instrument through bone
US7083620B2 (en) * 2002-10-30 2006-08-01 Medtronic, Inc. Electrosurgical hemostat
US7317950B2 (en) * 2002-11-16 2008-01-08 The Regents Of The University Of California Cardiac stimulation system with delivery of conductive agent
GB0304281D0 (en) * 2003-02-25 2003-03-26 Secretary Trade Ind Brit Ultrasound power sensor
US7497857B2 (en) 2003-04-29 2009-03-03 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US20060241522A1 (en) * 2003-06-18 2006-10-26 Chandraratna Premindra A Ultrasound devices and methods for treating ischemia and other cardiovascular disorders
US7678104B2 (en) * 2003-07-17 2010-03-16 Biosense Webster, Inc. Ultrasound ablation catheter and method for its use
US20050059448A1 (en) * 2003-09-11 2005-03-17 Scott Sims Method and apparatus for playing card game
US7247141B2 (en) 2004-03-08 2007-07-24 Ethicon Endo-Surgery, Inc. Intra-cavitary ultrasound medical system and method
US20050228286A1 (en) * 2004-04-07 2005-10-13 Messerly Jeffrey D Medical system having a rotatable ultrasound source and a piercing tip
US20050240123A1 (en) * 2004-04-14 2005-10-27 Mast T D Ultrasound medical treatment system and method
US20050240105A1 (en) * 2004-04-14 2005-10-27 Mast T D Method for reducing electronic artifacts in ultrasound imaging
US20050240124A1 (en) * 2004-04-15 2005-10-27 Mast T D Ultrasound medical treatment system and method
US20050234438A1 (en) * 2004-04-15 2005-10-20 Mast T D Ultrasound medical treatment system and method
US7494467B2 (en) * 2004-04-16 2009-02-24 Ethicon Endo-Surgery, Inc. Medical system having multiple ultrasound transducers or an ultrasound transducer and an RF electrode
US8333764B2 (en) 2004-05-12 2012-12-18 Medtronic, Inc. Device and method for determining tissue thickness and creating cardiac ablation lesions
US8235909B2 (en) 2004-05-12 2012-08-07 Guided Therapy Systems, L.L.C. Method and system for controlled scanning, imaging and/or therapy
WO2005112812A1 (en) 2004-05-14 2005-12-01 Medtronic, Inc. Method and devices for treating atrial fibrillation by mass ablation
US20050256405A1 (en) * 2004-05-17 2005-11-17 Makin Inder Raj S Ultrasound-based procedure for uterine medical treatment
US7883468B2 (en) * 2004-05-18 2011-02-08 Ethicon Endo-Surgery, Inc. Medical system having an ultrasound source and an acoustic coupling medium
US7951095B2 (en) * 2004-05-20 2011-05-31 Ethicon Endo-Surgery, Inc. Ultrasound medical system
US20050261587A1 (en) * 2004-05-20 2005-11-24 Makin Inder R S Ultrasound medical system and method
US7473250B2 (en) * 2004-05-21 2009-01-06 Ethicon Endo-Surgery, Inc. Ultrasound medical system and method
US7695436B2 (en) * 2004-05-21 2010-04-13 Ethicon Endo-Surgery, Inc. Transmit apodization of an ultrasound transducer array
US20050261588A1 (en) * 2004-05-21 2005-11-24 Makin Inder Raj S Ultrasound medical system
EP1750608B1 (en) 2004-06-02 2012-10-03 Medtronic, Inc. Ablation device with jaws
US20100145331A1 (en) * 2004-06-02 2010-06-10 Chrisitian Steven C Loop Ablation Apparatus and Method
WO2005120375A2 (en) * 2004-06-02 2005-12-22 Medtronic, Inc. Loop ablation apparatus and method
WO2005120374A1 (en) * 2004-06-02 2005-12-22 Medtronic, Inc. Compound bipolar ablation device and method
ATE516762T1 (en) * 2004-06-02 2011-08-15 Medtronic Inc ABLATION AND STAPLE INSTRUMENT
US7806839B2 (en) * 2004-06-14 2010-10-05 Ethicon Endo-Surgery, Inc. System and method for ultrasound therapy using grating lobes
US8409219B2 (en) 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
US8663245B2 (en) 2004-06-18 2014-03-04 Medtronic, Inc. Device for occlusion of a left atrial appendage
US8926635B2 (en) * 2004-06-18 2015-01-06 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
US7824348B2 (en) 2004-09-16 2010-11-02 Guided Therapy Systems, L.L.C. System and method for variable depth ultrasound treatment
US7393325B2 (en) 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US7134543B2 (en) * 2004-09-22 2006-11-14 Frito-Lay North America, Inc. Containment apparatus for multi-pass ovens
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US8663112B2 (en) 2004-10-06 2014-03-04 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
EP1879502A2 (en) 2004-10-06 2008-01-23 Guided Therapy Systems, L.L.C. Method and system for cosmetic enhancement
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
KR101605527B1 (en) 2004-10-06 2016-03-22 가이디드 테라피 시스템스, 엘.엘.씨. Ultrasound treatment system
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
US7833221B2 (en) * 2004-10-22 2010-11-16 Ethicon Endo-Surgery, Inc. System and method for treatment of tissue using the tissue as a fiducial
US20060089626A1 (en) * 2004-10-22 2006-04-27 Vlegele James W Surgical device guide for use with an imaging system
US7452357B2 (en) * 2004-10-22 2008-11-18 Ethicon Endo-Surgery, Inc. System and method for planning treatment of tissue
US8617152B2 (en) * 2004-11-15 2013-12-31 Medtronic Ablation Frontiers Llc Ablation system with feedback
US7468062B2 (en) 2004-11-24 2008-12-23 Ablation Frontiers, Inc. Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US7429261B2 (en) * 2004-11-24 2008-09-30 Ablation Frontiers, Inc. Atrial ablation catheter and method of use
JP2008521547A (en) * 2004-11-30 2008-06-26 オムニソニックス メディカル テクノロジーズ インコーポレイテッド Ultrasonic medical equipment with variable frequency drive
JP4695188B2 (en) 2005-04-25 2011-06-08 アーデント サウンド, インコーポレイテッド Method and apparatus for improving the safety of computer peripherals
US20060270900A1 (en) * 2005-05-26 2006-11-30 Chin Albert K Apparatus and methods for performing ablation
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
AU2006262447A1 (en) 2005-06-20 2007-01-04 Medtronic Ablation Frontiers Llc Ablation catheter
US8834461B2 (en) 2005-07-11 2014-09-16 Medtronic Ablation Frontiers Llc Low power tissue ablation system
US20070016184A1 (en) * 2005-07-14 2007-01-18 Ethicon Endo-Surgery, Inc. Medical-treatment electrode assembly and method for medical treatment
US8657814B2 (en) 2005-08-22 2014-02-25 Medtronic Ablation Frontiers Llc User interface for tissue ablation system
US9675821B2 (en) * 2006-03-14 2017-06-13 Boston Scientific Scimed, Inc. Device for thermal treatment of tissue and for temperature measurement of tissue providing feedback
DE502007003306D1 (en) * 2006-04-27 2010-05-12 Erbe Elektromedizin DEVICE FOR TREATING HUMAN OR ANIMAL TISSUE BY MEANS OF A MAGNETICALLY MOVABLE INSTRUMENT
US20080039746A1 (en) 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US7678109B2 (en) * 2006-06-23 2010-03-16 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation device and method comprising movable ablation elements
WO2008022122A2 (en) * 2006-08-14 2008-02-21 Buja Frederick J System and method employing a thermocouple junction for monitoring of physiological parameters
US9566454B2 (en) 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
US9314298B2 (en) 2007-04-17 2016-04-19 St. Jude Medical, Atrial Fibrillation Divisions, Inc. Vacuum-stabilized ablation system
ES2699477T3 (en) 2007-05-07 2019-02-11 Guided Therapy Systems Llc Methods and systems for coupling and focusing acoustic energy using a coupling member
EP2152351B1 (en) 2007-05-07 2016-09-21 Guided Therapy Systems, L.L.C. Methods and systems for modulating medicants using acoustic energy
US20150174388A1 (en) 2007-05-07 2015-06-25 Guided Therapy Systems, Llc Methods and Systems for Ultrasound Assisted Delivery of a Medicant to Tissue
US8641704B2 (en) * 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
EP2209517A4 (en) 2007-10-05 2011-03-30 Maquet Cardiovascular Llc Devices and methods for minimally-invasive surgical procedures
US20090299352A1 (en) * 2007-12-21 2009-12-03 Boston Scientific Scimed, Inc. Steerable laser-energy delivery device
JP5443386B2 (en) 2007-12-28 2014-03-19 サリエント・サージカル・テクノロジーズ・インコーポレーテッド Fluid-assisted electrosurgical device, method and system
US8821488B2 (en) * 2008-05-13 2014-09-02 Medtronic, Inc. Tissue lesion evaluation
KR102147455B1 (en) 2008-06-06 2020-08-24 얼테라, 인크 Ultrasound treatment system
WO2010019481A1 (en) 2008-08-11 2010-02-18 Conceptx Medical, Inc. Systems and methods for treating dyspnea, including via electrical afferent signal blocking
US10028753B2 (en) 2008-09-26 2018-07-24 Relievant Medsystems, Inc. Spine treatment kits
JP5688022B2 (en) 2008-09-26 2015-03-25 リリーバント メドシステムズ、インコーポレイテッド System and method for guiding an instrument through the interior of a bone
US10820825B2 (en) * 2008-10-22 2020-11-03 Cornell University Method and device for evaluation of local tissue's biological or biomechanical character
US9254168B2 (en) 2009-02-02 2016-02-09 Medtronic Advanced Energy Llc Electro-thermotherapy of tissue using penetrating microelectrode array
WO2010096809A1 (en) 2009-02-23 2010-08-26 Salient Surgical Technologies, Inc. Fluid-assisted electrosurgical device and methods of use thereof
CN102497832B (en) 2009-09-08 2015-09-09 显著外科技术公司 For case assembly and the using method thereof of electro-surgical device, electrosurgical unit
US8715186B2 (en) 2009-11-24 2014-05-06 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
EP2544616B1 (en) 2010-03-11 2017-09-06 Medtronic Advanced Energy LLC Bipolar electrosurgical cutter with position insensitive return electrode contact
US9242122B2 (en) 2010-05-14 2016-01-26 Liat Tsoref Reflectance-facilitated ultrasound treatment and monitoring
US8617150B2 (en) * 2010-05-14 2013-12-31 Liat Tsoref Reflectance-facilitated ultrasound treatment
US8956346B2 (en) 2010-05-14 2015-02-17 Rainbow Medical, Ltd. Reflectance-facilitated ultrasound treatment and monitoring
US8986205B2 (en) 2010-05-14 2015-03-24 Frederick J. Buja Sensor for measurement of temperature and pressure for a cyclic process
US20110295249A1 (en) * 2010-05-28 2011-12-01 Salient Surgical Technologies, Inc. Fluid-Assisted Electrosurgical Devices, and Methods of Manufacture Thereof
US9138289B2 (en) 2010-06-28 2015-09-22 Medtronic Advanced Energy Llc Electrode sheath for electrosurgical device
US8906012B2 (en) 2010-06-30 2014-12-09 Medtronic Advanced Energy Llc Electrosurgical devices with wire electrode
US8920417B2 (en) 2010-06-30 2014-12-30 Medtronic Advanced Energy Llc Electrosurgical devices and methods of use thereof
KR101939725B1 (en) 2010-08-02 2019-01-17 가이디드 테라피 시스템스, 엘.엘.씨. System and Method for Ultrasound Treatment
US9504446B2 (en) 2010-08-02 2016-11-29 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
US8585601B2 (en) 2010-10-18 2013-11-19 CardioSonic Ltd. Ultrasound transducer
JP2013543423A (en) 2010-10-18 2013-12-05 カーディオソニック リミテッド Tissue treatment
US9566456B2 (en) 2010-10-18 2017-02-14 CardioSonic Ltd. Ultrasound transceiver and cooling thereof
US9028417B2 (en) 2010-10-18 2015-05-12 CardioSonic Ltd. Ultrasound emission element
US9023040B2 (en) 2010-10-26 2015-05-05 Medtronic Advanced Energy Llc Electrosurgical cutting devices
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding
US9427281B2 (en) 2011-03-11 2016-08-30 Medtronic Advanced Energy Llc Bronchoscope-compatible catheter provided with electrosurgical device
KR102068724B1 (en) 2011-07-10 2020-01-21 가이디드 테라피 시스템스, 엘.엘.씨. Systems and methods for improving an outside appearance of skin using ultrasound as an energy source
EP2731675B1 (en) * 2011-07-11 2023-05-03 Guided Therapy Systems, L.L.C. Systems and methods for coupling an ultrasound source to tissue
US9750565B2 (en) 2011-09-30 2017-09-05 Medtronic Advanced Energy Llc Electrosurgical balloons
US8870864B2 (en) 2011-10-28 2014-10-28 Medtronic Advanced Energy Llc Single instrument electrosurgery apparatus and its method of use
US10390877B2 (en) 2011-12-30 2019-08-27 Relievant Medsystems, Inc. Systems and methods for treating back pain
US9707414B2 (en) 2012-02-14 2017-07-18 Rainbow Medical Ltd. Reflectance-facilitated ultrasound treatment and monitoring
US9263663B2 (en) 2012-04-13 2016-02-16 Ardent Sound, Inc. Method of making thick film transducer arrays
US10357304B2 (en) 2012-04-18 2019-07-23 CardioSonic Ltd. Tissue treatment
CN107693114A (en) 2012-04-24 2018-02-16 西比姆公司 The catheter in blood vessel and method extractd for carotid body
US11357447B2 (en) 2012-05-31 2022-06-14 Sonivie Ltd. Method and/or apparatus for measuring renal denervation effectiveness
WO2013181660A1 (en) 2012-06-01 2013-12-05 Cibiem, Inc. Methods and devices for cryogenic carotid body ablation
US9955946B2 (en) 2014-03-12 2018-05-01 Cibiem, Inc. Carotid body ablation with a transvenous ultrasound imaging and ablation catheter
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
CN104902836B (en) 2012-11-05 2017-08-08 毕达哥拉斯医疗有限公司 Controlled tissue melts
US9770593B2 (en) 2012-11-05 2017-09-26 Pythagoras Medical Ltd. Patient selection using a transluminally-applied electric current
IL238516B (en) 2012-11-05 2022-08-01 Relievant Medsystems Inc System and methods for creating curved paths through bone and modulating nerves within the bone
US20140243809A1 (en) * 2013-02-22 2014-08-28 Mark Gelfand Endovascular catheters for trans-superficial temporal artery transmural carotid body modulation
CN104027893B (en) 2013-03-08 2021-08-31 奥赛拉公司 Apparatus and method for multi-focal ultrasound therapy
WO2014146022A2 (en) 2013-03-15 2014-09-18 Guided Therapy Systems Llc Ultrasound treatment device and methods of use
WO2014188430A2 (en) 2013-05-23 2014-11-27 CardioSonic Ltd. Devices and methods for renal denervation and assessment thereof
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
EP2853364A1 (en) * 2013-09-27 2015-04-01 A O Schallinox GmbH Handheld tool for machining a process material
EP3131630B1 (en) 2014-04-18 2023-11-29 Ulthera, Inc. Band transducer ultrasound therapy
US10478249B2 (en) 2014-05-07 2019-11-19 Pythagoras Medical Ltd. Controlled tissue ablation techniques
US9974599B2 (en) 2014-08-15 2018-05-22 Medtronic Ps Medical, Inc. Multipurpose electrosurgical device
US9763684B2 (en) 2015-04-02 2017-09-19 Med-Sonics Corporation Devices and methods for removing occlusions from a bodily cavity
US10383685B2 (en) 2015-05-07 2019-08-20 Pythagoras Medical Ltd. Techniques for use with nerve tissue
JP2018526079A (en) * 2015-08-13 2018-09-13 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー Acoustic module and control system for portable ultrasonic device
US11389227B2 (en) 2015-08-20 2022-07-19 Medtronic Advanced Energy Llc Electrosurgical device with multivariate control
US11051875B2 (en) 2015-08-24 2021-07-06 Medtronic Advanced Energy Llc Multipurpose electrosurgical device
US10716612B2 (en) 2015-12-18 2020-07-21 Medtronic Advanced Energy Llc Electrosurgical device with multiple monopolar electrode assembly
IL259944B (en) 2016-01-18 2022-07-01 Ulthera Inc Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof
DE102016104097A1 (en) * 2016-03-07 2017-09-07 Biotronik Se & Co. Kg Implant and method of operating the same
US11678932B2 (en) 2016-05-18 2023-06-20 Symap Medical (Suzhou) Limited Electrode catheter with incremental advancement
BR112018072101B1 (en) 2016-08-16 2024-01-02 Ulthera, Inc SYSTEMS AND METHODS FOR COSMETIC SKIN TREATMENT WITH ULTRASOUND
US20200094080A1 (en) 2017-03-20 2020-03-26 Sonivie Ltd. Method for treating heart failure by improving ejection fraction of a patient
EP4027912A4 (en) 2019-09-12 2023-08-16 Relievant Medsystems, Inc. Systems and methods for tissue modulation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447509A (en) * 1991-01-11 1995-09-05 Baxter International Inc. Ultrasound catheter system having modulated output with feedback control
US5484400A (en) * 1992-08-12 1996-01-16 Vidamed, Inc. Dual channel RF delivery system
US5542916A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Dual-channel RF power delivery system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU132884A (en) * 1984-07-26 1987-12-31 Branko Breyer Electrode cateter with ultrasonic marking
US4808948A (en) * 1987-09-28 1989-02-28 Kulicke And Soffa Indusries, Inc. Automatic tuning system for ultrasonic generators
DE69233091T2 (en) * 1991-11-08 2004-05-06 Boston Scientific Ltd., St. Michael ABLATION ELECTRODE WITH INSULATED TEMPERATURE MEASURING ELEMENT
US5304214A (en) * 1992-01-21 1994-04-19 Med Institute, Inc. Transurethral ablation catheter
US5295484A (en) * 1992-05-19 1994-03-22 Arizona Board Of Regents For And On Behalf Of The University Of Arizona Apparatus and method for intra-cardiac ablation of arrhythmias
US5431664A (en) * 1994-04-28 1995-07-11 Alcon Laboratories, Inc. Method of tuning ultrasonic devices
US5635619A (en) * 1994-07-12 1997-06-03 Iowa State University Research Foundation, Inc. Apparatus and method for driving an ultrasonic transducer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447509A (en) * 1991-01-11 1995-09-05 Baxter International Inc. Ultrasound catheter system having modulated output with feedback control
US5484400A (en) * 1992-08-12 1996-01-16 Vidamed, Inc. Dual channel RF delivery system
US5542916A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Dual-channel RF power delivery system

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6001069A (en) * 1997-05-01 1999-12-14 Ekos Corporation Ultrasound catheter for providing a therapeutic effect to a vessel of a body
WO1998048711A1 (en) * 1997-05-01 1998-11-05 Ekos Corporation Ultrasound catheter
US8690818B2 (en) 1997-05-01 2014-04-08 Ekos Corporation Ultrasound catheter for providing a therapeutic effect to a vessel of a body
US6723063B1 (en) 1998-06-29 2004-04-20 Ekos Corporation Sheath for use with an ultrasound element
WO2000016704A1 (en) * 1998-09-24 2000-03-30 Ekos Corporation Ultrasound catheter for improving blood flow to the heart
US6312402B1 (en) 1998-09-24 2001-11-06 Ekos Corporation Ultrasound catheter for improving blood flow to the heart
US9415242B2 (en) 2001-12-03 2016-08-16 Ekos Corporation Catheter with multiple ultrasound radiating members
US10926074B2 (en) 2001-12-03 2021-02-23 Ekos Corporation Catheter with multiple ultrasound radiating members
US10080878B2 (en) 2001-12-03 2018-09-25 Ekos Corporation Catheter with multiple ultrasound radiating members
US6979293B2 (en) 2001-12-14 2005-12-27 Ekos Corporation Blood flow reestablishment determination
WO2003051208A1 (en) * 2001-12-14 2003-06-26 Ekos Corporation Blood flow reestablishment determination
US9943675B1 (en) 2002-04-01 2018-04-17 Ekos Corporation Ultrasonic catheter power control
US8852166B1 (en) 2002-04-01 2014-10-07 Ekos Corporation Ultrasonic catheter power control
US9107590B2 (en) 2004-01-29 2015-08-18 Ekos Corporation Method and apparatus for detecting vascular conditions with a catheter
US8585685B2 (en) 2006-04-27 2013-11-19 Erbe Elektromedizin Gmbh Device for treatment of human or animal tissue by means of a magnetically movable instrument
US11925367B2 (en) 2007-01-08 2024-03-12 Ekos Corporation Power parameters for ultrasonic catheter
US11672553B2 (en) 2007-06-22 2023-06-13 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US11458290B2 (en) 2011-05-11 2022-10-04 Ekos Corporation Ultrasound system
US9713481B2 (en) 2012-10-16 2017-07-25 Med-Sonics Corporation Apparatus and methods for transferring ultrasonic energy to a bodily tissue
US9615844B2 (en) 2012-11-06 2017-04-11 Med-Sonics Corporation Systems and methods for controlling delivery of ultrasonic energy to a bodily tissue
US10052120B2 (en) 2012-11-06 2018-08-21 Med-Sonics Corp. Systems and methods for controlling delivery of ultrasonic energy to a bodily tissue
CN104780858A (en) * 2012-11-06 2015-07-15 迈迪生医疗器械公司 Systems and methods for controlling delivery of ultrasonic energy to a bodily tissue
EP2916756A4 (en) * 2012-11-06 2016-07-13 Med Sonics Corp Systems and methods for controlling delivery of ultrasonic energy to a bodily tissue
US10092742B2 (en) 2014-09-22 2018-10-09 Ekos Corporation Catheter system
US10507320B2 (en) 2014-09-22 2019-12-17 Ekos Corporation Catheter system
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
US11740138B2 (en) 2015-06-10 2023-08-29 Ekos Corporation Ultrasound catheter

Also Published As

Publication number Publication date
JP2000500059A (en) 2000-01-11
US5735280A (en) 1998-04-07
EP0873082A1 (en) 1998-10-28
AU4336597A (en) 1998-04-14
CA2236255A1 (en) 1998-03-26
EP0873082A4 (en) 2001-02-14

Similar Documents

Publication Publication Date Title
US5735280A (en) Ultrasound energy delivery system and method
US5606974A (en) Catheter having ultrasonic device
US5596995A (en) Biomedical device having a temperature sensing system
EP1005838B1 (en) Ablation system with a split tip catheter, switching and measuring capabilities
US6063078A (en) Method and apparatus for tissue ablation
US5718701A (en) Ablation electrode
EP0566725B1 (en) Ablation electrode with insulated temperature sensing elements
US9014814B2 (en) Methods of determining tissue contact based on radiometric signals
US5722975A (en) Systems for radiofrequency ablation with phase sensitive power detection and control
EP1169972B1 (en) Mapping and ablation catheter
US9050105B2 (en) Catheter with multiple irrigated electrodes and a force sensor
US9539056B2 (en) Catheter with multiple irrigated electrodes and a force sensor
WO1995008943A2 (en) Apparatus and method for detecting contact pressure
WO1996034567A1 (en) System for controlling the energy delivered to a patient for ablation
JPH07500757A (en) System and method for ablating tissue while monitoring tissue impedance
US20130172869A1 (en) Systems and methods using sensors that resonate at a frequency equal to a resonance frequency of an ablated tissue
CA2896195A1 (en) Catheter with multiple irrigated electrodes and a force sensor
US20200030024A1 (en) Flexible-circuit tip for a split-tip catheter
EP3962352A1 (en) Monophasic-enabled catheter with microelectrodes and method of using same for local detection of signals
AU2014202924A1 (en) Systems and methods for radiometrically measuring temperature and detecting tissue contact prior to and during tissue ablation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD GH

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT

ENP Entry into the national phase

Ref document number: 2236255

Country of ref document: CA

Ref country code: CA

Ref document number: 2236255

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997941463

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 514716

Kind code of ref document: A

Format of ref document f/p: F

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1997941463

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1997941463

Country of ref document: EP